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ABSTRACT 
 
Subarachnoid hemorrhage (SAH) causes 5% of all strokes and is responsible for about 18,000 
deaths per year in the United States (Aneurysmal Subarachnoid Hemorrhage, 2008). The 
incidence of SAH has been estimated at 6 to 8 per 100,000 persons per year (Linn, Rinkel, Algra, 
& van Gijn, 1996). In nearly 15% (range 5–34%) of patients with SAH, no source of hemorrhage 
can be identified via four-vessel cerebral angiography (Alen et al., 2003; Gupta et al., 2009), 
resulting in two major types of SAH: aneurysmal (ASAH) and nonaneurysmal (NASAH). 
Anecdotal evidence and contradictory research suggest that patients with NASAH experience 
some of the same health-related quality of life (HRQoL) issues as patients with ASAH. The 
purpose of this quantitative survey design study was to compare health-related quality of life 
(HRQoL) 1 to 3 years post-hemorrhage in patients who have experienced a NASAH to those 
who have experienced an ASAH. This is the first US study to specifically investigate HRQOL in 
NASAH and the second study comparing HRQOL outcomes between aneurysmal and 
nonaneurysmal subarachnoid hemorrhage patients. Our results are comparable to the first study 
by Hutter and Gilsbach, (1995), which also found that the two groups are much more similar 
than different. There were no significant differences between 28 of the 36 demographic and 
clinical characteristics examined in this study. Our study confirms previous findings that there is 
a significant impact on employment for both hemorrhage groups and an even greater inability to 
return to work for the NASAH patients.  The nonaneurysmal group had more physical symptom 
complaints while the aneurysmal group had more emotional symptoms.  Lastly, both groups had 
low levels of PTSD, and these levels did not differ significantly between groups. However, 
PTSD and social support were shown by regression analysis to impact HRQOL for both groups. 
We recommend that clinicians assess for PTSD in all subarachnoid hemorrhage patients and 
iv 
 
institute treatment early, which will decrease the negative effects on HRQOL. This may include 
offering psychological services or social work early in the hospital course to all SAH patients. 
Further research and policy changes are needed to assist in interventions that improve vocational 
reintegration after SAH. NASAH patients should no longer be referred to as having suffered a 
“benign hemorrhage.” They have had a life changing hemorrhage that may forever change their 
lives and impact their HRQOL 
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CHAPTER I  
 
STATE OF THE SCIENCE 
Introduction 
Subarachnoid hemorrhage (SAH) causes 5% of all strokes and is responsible for about 
18,000 deaths per year in the United States (Aneurysmal Subarachnoid Hemorrhage, 2008). The 
incidence of SAH has been estimated at 6 to 8 per 100,000 persons per year (Linn, Rinkel, Algra, 
& van Gijn, 1996). In nearly 15% (range 5–34%) of patients with SAH, no source of hemorrhage 
can be identified via four-vessel cerebral angiography (Alen et al., 2003; Gupta et al., 2009), 
resulting in two major types of SAH: aneurysmal (ASAH) and nonaneurysmal (NASAH).   
ASAH is defined as bleeding into the subarachnoid space that surrounds the brain (i.e., 
the area between the arachnoid membrane and the pia mater). ASAH may arise due to 
spontaneous rupture of an aneurysm. It is a medical emergency that, even if recognized and 
treated in an early stage, can lead to death or severe disability.   
NASAH is a nontraumatic, spontaneous SAH of unknown etiology, not visualized on a 
cerebral angiogram (Hermann & Zabramski, 2007).  Patients who experience NASAH differ 
from those who suffer an ASAH. NASAH has been described as a benign entity (Alen et al., 
2003; Beseoglu, Pannes, Steiger, & Hanggi, 2009; Gupta et al., 2009). The symptoms of 
NASAH differ slightly from those of ASAH, i.e., the headache generally starts over several 
minutes rather than the sudden thunderclap headache associated with ASAH (Rinkel et al., 
1990). Patients with NASAH, who are typically younger and male, may report other symptoms 
such as nausea, vomiting and photophobia (Herrmann & Zabramski, 2007).  In NASAH, the 
hemorrhage is classified as perimesencephalic or nonperimesencephalic. In a perimesencephalic 
hemorrhage the blood is confined to the cisterns around the midbrain and the center of the 
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bleeding is immediately anterior to the midbrain (Gupta et al., 2009). The population with 
perimesencephalic hemorrhage usually has a fairly benign and uncomplicated hospital course, 
whereas the nonperimesencephalic hemorrhage population tends to have more complications, 
similar to patients who have had ASAH (Alen et al., 2003; Beseoglu et al., 2009; Gupta et al., 
2009; Hermann & Zabramski, 2007).  
Anecdotal evidence and contradictory research suggest that patients with NASAH 
experience some of the same health-related quality of life (HRQoL) issues as patients with 
ASAH. Quality of life issues in the NASAH patient population have specifically been examined 
in five studies, four performed in Europe (Beseoglu et al., 2009; Brilstra, Hop, & Rinkel, 1997; 
Greebe & Rinkel, 2007; Marquardt, Niebauer, Schick, & Lorenz, 2000) and one in India (Gupta 
et al., 2009), with contradictory results. HRQoL was measured in many of these studies by tools 
such as the Rankin Score or Glasgow Outcome Scale (GOS), which are not good indicators of 
multidimensional domains of health-related quality of life. Patients in these studies might have 
been classified as having “good outcomes” or having a “benign hemorrhage,” without having 
returned to their pre-hemorrhage level of functioning. No US studies published thus far have 
specifically studied HRQoL in the NASAH patient population. The setting of previous studies 
may be important as the majority of European countries have a government-run health care 
system. To understand HRQoL issues in the US NASAH patient population, this study will use a 
survey design. The goal of the study was to detect the strength of association and differences in 
HRQoL between patients who experienced a NASAH versus an ASAH in the previous 1 to 3 
years. Factors influencing NASAH patients’ experiences of HRQoL issues were determined and 
compared to and adjusted to those of ASAH patients. 
.  
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Purpose Statement 
The purpose of this quantitative survey design study was to compare health-related 
quality of life (HRQoL) 1 to 3 years post-hemorrhage in patients who experienced a NASAH to 
those who have experienced an ASAH.  
Specific Aims 
1. To describe the physical, psychological, social, and vocational impact of nonaneurysmal and 
aneurysmal subarachnoid hemorrhage on patients at 1 to 3 years post-hemorrhage.  
2. To examine differences in HRQOL between patients with NASAH and ASAH after 
controlling for severity of hemorrhage, age, and time since event.   
3. To examine the effects of employment status, PTSD, and social support (by adjusting for each 
variable) on HRQOL for patients with NASAH and ASAH and determining if the adjustment 
accounts for any HRQoL differences between NASAH and ASAH patients.  
4. To describe management strategies used by patients with nonaneurysmal and aneurysmal 
subarachnoid hemorrhage that helped improve their HRQoL. 
Aneurysmal Subarachnoid Hemorrhage  
Incidence of ASAH 
 The international incidence of spontaneous SAH varies according to region, but affects 
approximately 7 to 9 of 100,000 people per year (de Rooij, Linn, van der Plas, Algra, & Rinkel, 
2007). Although women have historically been considered more likely than men to suffer from 
SAH (de Rooij et al., 2007), newer epidemiologic research reveals that this difference occurs 
only after the sixth decade of life (de Rooij et al., 2007). The most common cause of SAH is 
trauma as the corticomeningeal vessels are ruptured (Suarez, Tarr, & Selman, 2006).  Most 
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spontaneous causes of SAH are related to aneurysm rupture, which is the focus of this section 
(Suarez et al., 2006).   
Diagnosis of ASAH 
 Rupture of an aneurysm releases blood directly into the cerebrospinal fluid (CSF) under 
arterial pressure (Greenberg, 2005). The blood spreads quickly within the CSF, rapidly 
increasing intracranial pressure. The bleeding usually lasts only a few seconds, but re-bleeding is 
common and occurs more often within the first day (Greenberg, 2005). Consistent with the rapid 
spread of blood, the symptoms of SAH typically begin abruptly, occurring at night in 30% of 
cases. The premier symptom is a sudden, severe headache (97% of cases), classically described 
as the "worst headache of my life." The headache is lateralized in 30% of patients, predominantly 
to the side of the aneurysm (Greenberg, 2005; Thomas, Edlow, & Goldstein, 2009). The onset of 
the headache may or may not be associated with a brief loss of consciousness, seizure, nausea, 
vomiting, or meningismus (Greenberg, 2005; Thomas et al., 2009).  
SAH blood will usually be seen on a non-contrast computed tomography (CT) scan of the 
head in SAH spaces, sometimes encircling the circle of Willis. If no blood is seen on a head CT, 
the next step would be to perform a lumbar puncture to rule out blood in the cerebrospinal fluid 
(Thomas et al., 2009). Finding blood in the CSF confirms the diagnosis of SAH.  Other 
diagnostic techniques, e.g., CT angiography (CTA) and magnetic resonance angiography 
(MRA), are noninvasive tests useful for screening and pre-surgical planning, but they do not 
achieve the resolution of angiography (Alen et al., 2003). MRA can identify aneurysms 3 to 5 
mm or larger. The sensitivity of CTA appears comparable to MRA, as aneurysms smaller than 3 
mm will be missed. Cerebral diagnostic angiogram has been considered the gold standard to 
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definitely diagnose or exclude aneurysm or arteriovenous malformations as the cause of 
subarachnoid hemorrhage (Thomas et al., 2009).  
ASAH Hospital Course 
ASAH patients are admitted to an intensive care unit where their neurological exam and 
vital signs are monitored closely (Greenberg, 2005; Hermann & Zabramski, 2007). Strict blood 
pressure control is important prior to repair of the aneurysm. The most recent American Heart 
Association guidelines recommend that “blood pressure should be monitored and controlled to 
balance the risk of stroke, hypertension-related bleeding, and maintenance of cerebral perfusion 
pressure” (Bederson et al., 2009, p. 1002). Bed rest with head of bed elevation greater than 30 
degrees is recommended to maintain venous outflow and minimize blood pressure fluctuations 
(Thomas et al., 2009). The treatment of a ruptured aneurysm is based on location and size of 
aneurysm (Greenberg, 2005). Two methods are widely available but depend on the medical 
center’s capabilities and surgeon preference. Open surgical clipping via craniotomy was once the 
traditional method for securing a ruptured aneurysm and is still used today (Bederson et al., 
2009). However, the more commonly used method is an endovascular packing of the aneurysm 
with titanium coils. Each procedure has its own set of risks and benefits (Bederson et al., 2009). 
 Standard postoperative treatment includes monitoring the patient for cerebral vasospasm, 
a delayed complication that may develop several days to 2 weeks post-SAH, peaking 7 to 10 
days after the event (Greenberg, 2005). Vasospasm may be asymptomatic or may lead to delayed 
cerebral ischemic infarcts, which can cause significant morbidity related to SAH (Greenberg, 
2005). Nimodipine, a calcium channel blocker, has been shown to improve outcomes (risk ratio 
0.67; 95% confidence interval, 0.55-0.81) of death or dependence (Bederson et al., 2009). When 
patients are confirmed to have vasospasm, they receive hyperdynamic therapy, i.e., intravenous 
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fluids and vasopressor medications to cause hypervolemia, hypertension, and hemodilution 
(Greenberg, 2005).  Patients’ blood chemistry results should be closely monitored for 
hyponatremia, a common complication of SAH (Hermann & Zabramski, 2007). Depending on 
the patient’s neurological deficits, complications and presence of vasospasm will determine 
length of hospital course (Bederson et al., 2009; Greenberg, 2005; Hermann & Zabramski, 
2007). 
Nonaneurysmal Subarachnoid Hemorrhage 
Incidence of NASAH. In nearly 15% of patients with spontaneous nontraumatic 
subarachnoid hemorrhage, no obvious source of hemorrhage can be demonstrated on diagnostic 
cerebral angiography (Alen et al., 2003; Gupta et al., 2009; Hermann & Zabramski, 2007; 
Wijdicks, Schievink, & Miller, 1998 a.b). Of these patients, 21% to 68% are known to have 
perimesencephalic hemorrhage (Gupta et al., 2009), which is typical in younger and male 
patients (Hermann & Zabramski, 2007). In perimesencephalic hemorrhage, the blood is confined 
to the cisterns around the midbrain and the center of the bleeding is immediately anterior to the 
midbrain (Gupta et al., 2009). Thus, the population of patients with perimesencephalic 
hemorrhage usually has a fairly benign and uncomplicated hospital course (Alen et al., 2003; 
Beseoglu et al., 2009; Gupta et al., 2009; Hermann & Zabramski, 2007). A significant percentage 
of the NASAH population presents a nonperimesencephalic pattern of blood, where the 
hemorrhage is located in the other subarachnoid, intracerebral, ventricular spaces (Beseoglu et 
al., 2009).  For patients with this NASAH, the incidence, clinical course, and outcomes are not 
well described (Gupta et al., 2009).  
NASAH Hospital Course. A gradual onset of a severe headache over several minutes has 
been reported in patients with NASAH (Hermann & Zabramski, 2007). Patients may also report 
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associated symptoms such as nausea, vomiting, and photophobia. These patients may also be 
reported by their significant others to have an altered level of consciousness (Hermann & 
Zabramski, 2007). Once the patient has had a full examination, other pertinent information 
should be obtained such as history of recent drug use, hypertension, polycystic kidney disease, 
and history of other aneurysms (Gupta et al., 2009; Hermann & Zabramski, 2007; Wijdicks et al., 
1998a,b). Another important question is family history. Two family members in a study of 24 
patients with perimesencephalic NASAH, were found to have a subarachnoid bleed from a brain 
aneurysm (Wijdicks et al., 1998a). Genetic predisposition to various vascular abnormalities, 
including intracranial aneurysms, has been well documented (Hermann & Zabramski, 2007; 
Wijdicks et al., 1998a). 
 A CT scan of the brain is usually the first step to rule out other pathologies that may 
mimic a subarachnoid hemorrhage (Hermann & Zabramski, 2007). CT angiography may be 
performed to determine the source of the hemorrhage. In patients with ruptured aneurysms the 
reported sensitivity is 86% (Alen et al., 2003; Hermann & Zabramski, 2007; Wijdicks et al., 
1998b). However, the gold standard remains the diagnostic cerebral angiogram, which is likely 
needed to evaluate cerebral circulation for the source of SAH: aneurysm, ateriovenous 
malformation, or dural arteriovenous fistula (Alen et al., 2003; Hermann & Zabramski, 2007; 
Wijdicks et al., 1998b). A negative angiogram may be followed up by magnetic resonance 
imaging (MRI) scan of the brain and possibly spine to rule out a tumor and other vascular 
abnormalities (Alen et al., 2003; Hermann & Zabramski, 2007; Wijdicks et al., 1998b). In a 
significant percentage of patients with spontaneous subarachnoid hemorrhage, the initial 
angiographic studies do not reveal an aneurysm or other vascular abnormality; indeed, some of 
these patients’ angiograms can yield false-negative results (Gupta et al., 2009). It is controversial 
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whether to repeat the cerebral angiogram from 5 days up to 6 weeks after initial bleed (Gupta et 
al., 2009; Hermann & Zabramski, 2007; Wijdicks et al., 1998b).  
 At this author’s medical institution, protocols for NASAH include admission to an ICU 
setting for close neurological monitoring, further imaging with CTA, followed by diagnostic 
cerebral angiogram. If negative, the angiogram is followed by MRI of the brain and spine. These 
patients are also kept on bed rest, and given Nimodipine, a calcium channel blocker, and 
additional medication if needed to keep their blood pressure within a normal range. These 
protocols are consistent with previous reports (Hermann & Zabramski, 2007; Wijdicks et al., 
1998a, b). Patients are monitored closely for vasospasm, which can occur in patients who suffer 
a subarachnoid hemorrhage but are uncommon in NASAH patients (Hermann & Zabramski, 
2007). For example, vasospasm was reported in 4 of 24 nonaneurysmal patients (16%, Wijdicks 
et al., 1998b), in 2 of 65 patients (3%, Schievink, Eelco, & Spetzler, 2000), and in 1 of 26 
patients (3%, Beseoglu et al., 2009). A case study report of vasospasm in perimesencephalic 
NASAH patients (Schievink et al., 2000) concluded that these patients are at risk for vasospasm 
and should be treated with prophylactic nimodipine, a calcium channel blocker shown to prevent 
major complications from vasospasm in SAH patients (Allen et al., 1983). 
Vasospasm, if not quickly identified and treated, can lead to cerebral ischemia and stroke. 
Thus, some clinicians will observe this population in an ICU setting until the second angiogram 
is negative. If the second angiogram is negative and the neurological exam is normal, the 
NASAH patient will be transferred to the neurosurgical unit and observed for 1 to 2 more days 
until the headache or any other issues can be managed at home. NASAH patients often report 
anxiety about having another hemorrhage as well as concerns about headaches, short-term 
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memory problems, and going back to work (Greebe & Rinkel, 2007; Hermann & Zabramski, 
2007).     
Measures Used to Assess Health Outcomes in the SAH Population 
Health outcomes have commonly been assessed in the SAH population using seven tools: 
the modified Rankin Scale (mRS), (Bonita & Beaglehole, 1988), Glasgow Outcome Score 
(GOS), (Jennette& Bond (1975), Barthel Index (Mahoney & Barthel, 1965), National Institute of 
Health Stroke Scale (NIHSS), (Brott et al., 1989), the Medical Outcomes Study Short Form-36 
(SF-36),(The SF-36/org), the Mini-Mental Status Examination (MMSE), Folstein, Folstein, & 
McHugh (1975)., and the Stroke-Specific Quality of Life Scale (SS-QoL) (Williams,Weinberger, 
Harris, Clark & Biller, 1999)). The first six instruments were compared in a prospective study on 
the utility of QoL health-outcome measures to assess 385 patients 3 to 12 months after 
intracranial aneurysm treatment (Kim, Haney, & Van Ginhoven, 2005). The study reported three 
main findings. First, the Barthel Index and NIHSS were not useful in the aneurysmal population, 
due to most survivors achieving maximal scores by 3 months. Second, the Rankin and Glasgow 
scales were poorly correlated with the MMSE and SF-36, indicating that patients with significant 
cognitive or QoL issues can be graded at a high level of function. This finding is not unexpected 
as the Rankin and Glasgow scales measure degree of disability and not QoL. Lastly, the Rankin, 
GOS, MMSE, and SF-36 showed statistically significant differences in outcomes for patients 
with different initial clinical presentations.  The authors recommend that the recovery of ASAH 
patients should not be assessed only by a simple graded scale, but supplemented with MMSE and 
SF-36 assessments (Kim et al., 2005).  
 The seventh instrument, the SS-QoL was recently validated in 141 patients with ASAH 
(Boosman, Passier, Visser-Meily, Rinkel, & Post, 2009). The 49-item SS-QoL measures QoL in 
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12 domains: self-care, mobility, upper extremity function, language, vision, work, thinking, 
family roles, social roles, personality, mood, and energy. Internal consistency was good 
(alpha>.80) for all 12 domains (Boosman et al., 2009). 
 A recent meta-analysis by Noble & Schenk (2010) studied variables to explain poor 
health related quality of life after SAH. They included studies which HRQoL had been measured 
using a Sickness Impact Profile (SIP), Functional Limitation Profile, Functional Limitations 
Profile, Aachen Life Quality Inventory or MOS Short Form HRQoL questionnaire (Short Form 
36 and Short Form 12). Twelve articles were examined, using the predictor patient age, sex of 
patient, age, clinical severity, bleed severity and cognitive impairment. Only the variable of 
physical disability (effect size .54) was found to be a useful predictor of poor HRQoL. Age also 
needs to be considered as a predictor value with an effect size of .20. The traditional variables 
cited in other studies such as sex, severity of bleed, clinical severity of bleed at the time of 
admission to the hospital, time between SAH and assessment of HRQoL  have only minimal 
effects on patients’ physical and mental HRQoL. 
Quality of Life in the ASAH Population 
 Quality of life (QoL) after aneurysmal subarachnoid hemorrhage has been examined in 
eight European studies conducted in Germany (Hutter & Gilsbach, 1995; Hutter, Kreitschmann-
Andermahr, & Gilsbach, 2001; Scharbrodt, Stein, Schriber, Boker, & Oertel, 2009), the 
Netherlands (Hop, Rinkel, Algra, & van Gijn, 1998; Hop, Rinkel, Algra, & van Gijn, 2001; 
Visser-Meily, Rhebergen, Rinkel, van Zandvoort, & Post, 2009;Wermer, Kool, Albrecht, & 
Rinkel, 2007;), and Spain (Katati et al., 2007).  These studies demonstrate long-term QoL was 
predicted by neurological exam on admission, size of bleed, and age. The long term physical 
effects of ASAH effects physical/emotional health and have interfered with ability to work. The 
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first study examined, Hutter & Gilsbach (1995), is the only study that includes NASAH in its 
study population.  
Quality of life was studied retrospectively 1- 5 years after their SAH, in 36 German 
ASAH and NASAH patients (Hutter & Gilsbach, 1995). About half these patients (51%) initially 
presented in the emergency department with an altered mental status and 93% had diffuse 
subarachnoid blood or clot on CT on arrival at the hospital. These data are important because 
NASAH patients generally have a small amount of blood or clotting and minimally altered 
mental status. Participants were assessed for QoL using an 11-item self-rated scale and a parallel 
version rated by their life-companions. The emotional state of participants was tested using the 
Freiburg Personality Inventory (FPI-R). Substantial impairments in QoL were reported by 50% 
of patients and their life companions, but proxy ratings were consistently lower. In particular, 
QoL was reduced in terms of motivation (41%), life satisfaction (48%), mental capacity (47%), 
free-time activities (52%), social relationships (39%), concentration (70%), free motor 
coordination (25%), and sleep (47%). Self-reported ratings on reduced motivation and free-time 
activities correlated well with FPI-R scores for loss of motivation (r= 0.46, p<0.01).  Participants 
reported employment-related difficulties (n=5, 8%), lost their job or were demoted (n= 5, 8%), or 
had to retire (n=9, 15%). Depression was found in 17 patients (30%, Hutter & Gilsbach, 1995).  
This study provided insight into the neuropsychological component of subarachnoid 
hemorrhage. The authors concluded that ASAH and NASAH patients did not differ significantly 
in cognitive deficits, depression, and daily life restrictions. However, the findings of this study 
were limited by the small sample, use of multiple complex instruments to assess cognition and 
depression, and the lack of a standard, multidimensional measure of QoL, as demonstrated by 
lack of measurement of the physical domain (Ware, 1987).  
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Quality of life was examined in 116 German patients 4 to 5 years after aneurysmal bleed 
to determine whether brain location of hemorrhage influenced QoL (Hutter, Kreitschmann-
Andermahr, & Gilsbach, 2001). QoL was measured using the Aachen Life Quality Inventory, the 
German version of the Sickness Impact Profile (SIP), and found to be substantially influenced by 
patient’s age, neurological state on admission, and bleeding pattern, but not by location of the 
aneurysm. These findings were validated in a cohort of 128 German SAH patients approximately 
5 years post-hemorrhage (Scharbrodt, Stein, Schriber, Boker, & Oertel, 2009). Long-term QoL 
was predicted by neurological exam on admission, size of bleed, and age predicted long-term 
QoL. In that study, SAH negatively impacted QOL (measured by the SF-36) up to 5 years after 
the hemorrhage. The negative effects were most notable for, physical, social, and general health 
domains. 
QoL was studied prospectively in 64 Dutch patients and their significant others (Hop, 
Rinkel, Algra, & van Gijn, 1998) using the SF-36, SIP, and a 0-100 visual analog scale (VAS) 
that self-rated well-being before and after the hemorrhage. VAS, ranging from 0 (poor) to 100 
(excellent), with the following questions: “How did you do before your/your partner’s 
hemorrhage?” and “How are you now?” Patients and partners were asked to respond by putting a 
mark on the scale, taking into account their integrated physical, psychological, and social well-
being. Functional outcomes were assessed using the Rankin scale. QoL was often decreased on 
both SIP and SF-36 physical and psychosocial subscores of patients whose functional outcomes 
were reduced, but were independent (Rankin grades 1 to 3). Patients’ outcomes were referenced 
to a Dutch population assumed to have little to no functional disability. Good physical outcomes 
(Rankin grade 0, independent and recovered) did not correlate with psychosocial well-being. 
Patients’ employment issues were not addressed (Hop et al., 1998).  
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Quality of life in the same cohort of Dutch patients and their significant others was 
followed up 18 months later (Hop, Rinkel, Algra, & van Gijn, 2001). Again QoL was measured 
using the SF-36, SIP, and visual analogue scale, but functional outcomes were measured using a 
modified Rankin Scale (mRS). 32 patients (50%) improved at least 1 point on the mRS, in 23 
patients functional outcome remained unchanged, 6 patients deteriorated 1 point on the mRS, 
and 3 died. QOL of patients and caregivers did not change in terms of SIP scores, but SF-36 
scores improved QOL in patients with higher Rankin grades. On both instruments, QOL of all 
patients at 18 months was still lower than that of the reference population improved functional 
outcomes were correlated with higher SF-36 scores (assessed by subjective perceptions), but not 
with higher SIP scores (assessed by objective performance and behavior), contrary to intuitive 
expectations. Perhaps this finding is determined not so much by what the patient perceives they 
can do but rather what they can actually do. Patients who were able to return back to previous 
employment after the hemorrhage was very low, only 1 of 17 was able to return to their previous 
position. The authors concluded that functional outcomes improved significantly between 4 and 
18 months post-SAH and seemed to be accompanied by improved QoL (Hop et al., 2001).
 Similar findings have more recently been reported. For example, effects on employment, 
relationships, personality, and mood were studied in 610 Dutch patients on average 8.9 years 
after ASAH (Wermer, Kool, Albrecht, & Rinkel, 2007). Data on mood were collected using the 
Hospital Anxiety and Depression Scale (HADS).  The majority of patients (59%) reported 
changes in personality, 26% stopped working, and 24% worked shorter hours. The long-term 
psychosocial effects of SAH were considerable even in patients who regained functional control. 
 QoL was examined in 70 Spanish patients 4 months after ASAH using the SF-36 (Katati 
et al., 2007). In 60% of these patients, the most affected dimension was the physical role, i.e., 
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patients reported that their physical health interfered with their work and other daily tasks. The 
second most affected dimension was mental health, with 47.1% of patients suffering from 
depression, anxiety, and loss of control over their behavior and emotions. Katati et al. (2007) 
points out further evidence of similar findings by referring to the Hop et al., (2001) study that 
patients who have a Rankin score of zero (no physical disability) do not experience a reduction 
in their QoL, while those with a Rankin score of 4 (fully disabled) have severe deterioration. 
Finally, better QoL was predicted by male gender and absence of physical handicaps (Katati et 
al., 2007). Patients were assessed only 4 months after hemorrhage, when many may have only 
recently been able to return home. While these findings are useful for the acute care setting, they 
may not be applicable to long-term QoL, which was found to improve significantly from 4 to 18 
months post-SAH (Hop et al., 2001). HRQoL was measured in 141 community-dwelling Dutch 
patients 2-4 years post ASAH (Visser-Meily, Rhebergen, Rinkel, van Zandvoort, & Post, 2009). 
HRQoL (measured by the Stroke-Specific Quality of Life [SSQOL] scale) was examined in 
relation to psychological symptoms (mood disorders, fatigue, and cognitive complaints), 
personality characteristics (neuroticism and passive coping style), demographic characteristics, 
and subarachnoid hemorrhage disease characteristics. Patients were relatively satisfied with their 
HRQoL and generally scored higher in the physical domain and lower in the emotional and 
social domains. HRQoL was most strongly and inversely correlated with mood problems (0.73) 
and fatigue (0.73), and positively correlated with cognitive function (0.56). The other important 
finding of this study was that a measure of disability (the Glasgow Outcome Scale) was not 
useful in predicting long-term HRQoL (Visser-Meily et al., 2007).   
The above findings on ASAH patients (Hop et al., 1998, 2001; Hutter & Gilsbach, 1995; 
Hutter et al., 2005; Katati et al., 2007; Wermer et al., 2007) can be extrapolated to the NASAH 
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population. Generally, this latter population has smaller amounts of SAH blood (Alen et al., 
2003; Beseoglu et al., 2009; Gupta et al., 2009) and a better neurological exam after initial 
hemorrhage (Alen et al., 2003; Beseoglu et al., 2009; Gupta et al., 2009; Hermann & Zabramski, 
2007).  These characteristics allow one to infer that these patients would have higher QoL both 
in the short- and long-term. 
Quality of Life in the NASAH Population.  
 Quality of life issues in the NASAH patient population have specifically been examined 
in five studies, four performed in Europe (Beseoglu et al., 2009; Brilstra, Hop, & Rinkel, 1997; 
Greebe & Rinkel, 2007; Marquardt, Niebauer, Schick, & Lorenz, 2000) and one in India (Gupta 
et al., 2009), with contradictory results. HRQoL was measured in many of these studies by tools 
such as the Rankin Score or Glasgow Outcome Scale (GOS), which are not good indicators of 
multidimensional domains of health-related quality of life. Patients in these studies might have 
been classified as having “good outcomes” or having a “benign hemorrhage,” without having 
returned to their pre-hemorrhage level of functioning. No US studies published thus far have 
specifically studied HRQoL in the NASAH patient population. 
The first outcome study of perimesencephalic nonaneurysmal hemorrhage was completed 
in the early 1990s on 37 Dutch patients with persistent symptoms of headache and forgetfulness 
18 months to 7 years post-hemorrhage (Rinkel et al., 1990). The authors concluded that within 
this time frame, NASAH patients were not at risk for rebleeding and their QoL was not reduced. 
The same group of researchers later assessed the impact of these subtle changes on QoL in a 
prospective study of 25 Dutch perimesencephalic hemorrhage patients 6 months to 6 years post-
hemorrhage (Brilstra et al., 1997). QoL was assessed using the SIP supplemented with a few 
nonaneurysmal hemorrhage-related questions. Patients’ SIP scores demonstrated less 
 HRQOL in Subarachnoid Hemorrhage Patients 
17 
dysfunction than for the reference population (in which the Dutch version SIP had been 
validated), but the difference was only significant for physical subscores measuring ambulation, 
mobility, and self-care ability. Of the 25 patients, 6 (24%) reported more dysfunction in the 
category of work than the general population. Eleven patients reported more headaches than 
before the hemorrhage, and 2 patients reported fear of re-bleeding. Finally, two patients thought 
that their quality of life had improved since the hemorrhage, which the authors speculated might 
be related to having been an ICU patient (Brilstra et al., 1997). The results of this study are 
limited by the small sample, wide span of post-hemorrhage time at which subjects were assessed, 
and non-significant findings for SIP scores. 
 In contrast, NASAH patients were reported to have considerable long-term psychosocial 
issues (Marquardt et al., 2000). The sample comprised 21 German patients diagnosed with 
perimesencephalic nonaneurysmal subarachnoid hemorrhage 5 months to 3 years earlier and 
discharged in good clinical condition without neurological deficits. Patients were interviewed to 
evaluate degree of subjective recovery, residual complaints, and present occupational findings, 
but no information was provided about measurement tools, specific questions, statistics, or the 
interview procedures.  Eight patients (23%) considered themselves recovered and completely 
well, and 13 (62%) had residual complaints of headache, irritability, forgetfulness, depression, 
weariness, and reduced endurance. Of the 17 patients who had been working before the 
hemorrhage, 7 (41%) returned to their previous occupation, 9 (53%) retired from work, and 1 
became unemployed (Marquardt et al., 2000). The results of this study are limited by the small 
sample and lack of information about measurement tools. 
 NASAH patients were previously found to not be at risk for rebleeding and to not have 
reduced QoL within 18 months to 7 years of hemorrhage (Rinkel et al., 1990). To determine the 
 HRQOL in Subarachnoid Hemorrhage Patients 
18 
longer term outcomes after NASAH, Greebe and Rinkel (2007) studied a cohort of 160 Dutch 
patients who had suffered a perimesencephalic NASAH between 1983 and 2005 (1-23 years 
post-hemorrhage). For patients who had died in this cohort, standardized ratios were used to 
investigate possible excess mortality compared to that of the general population in 2000, the 
median year of hemorrhage in the cohort. Mortality ratios in the cohort were indirectly 
standardized according to age and sex to account for patients changing age strata during the 
long-term follow-up. Functional outcomes were assessed in structured telephone interviews by 
asking two simple questions: 1) Did patients need help from another person with daily activities? 
2) If not, did patients feel they had made a complete recovery? The authors provided references 
supporting the reliability and validity of these questions, but no psychometric parameters for 
their study (Greebe & Rinkel, 2007).  
Of the 160 patients in the cohort, 11 had died for reasons mostly unrelated to NASAH 
(myocardial infarction [n=2], cardiac failure [n=1], cerebral infarction [n=1], hepatic failure 
[n=1], gastric cancer [n=2], colon carcinoma [n=1], and infection at old age [n=3]). Of the 149 
living patients, 2 living in nursing homes were excluded (for reasons other than their NASAH). 
The remaining 147 patients were independent in activities of daily living, of whom 39 had 
symptoms including headaches or dizziness (n=7), fatigue (n=7), forgetfulness (n=12), and 
irritability (n=5), similar to those in a previous report (Marquardt et al., 2000). Greebe and 
Rinkel’s study showed that patients with perimesencephalic hemorrhage have no long-term 
excess mortality compared with general population. This information is important to alleviate 
patients’ anxiety about life expectancy and future bleeding and as evidence that insurance 
companies do not to impose additional liability based on patients’ diagnosed with 
perimesencephalic NASAH hemorrhage. 
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Nonperimesencephalic subarachnoid hemorrhage was concluded to be a benign entity 
based on 34 NASAH patients having good outcomes based only on Glasgow Outcome Scale 
(GOS) (Gupta et al., 2009). Patients underwent brain imaging upon admission and if the no 
aneurysm was found, they were imaged again 4-6 weeks later.  If the second scan revealed no 
aneurysm or other vascular abnormality, patients were labeled as nonaneurysmal SAH. Within 
this group, two types were identified: perimesencephalic SAH and nonperimesencephalic SAH. 
The incidence of hypertension/cardiac disease, diabetes and use of alcohol was higher in the 
NASAH population versus the ASAH group. The study results on nonperimesencephalic SAH 
need to be interpreted with caution, as 7 patients who died before the second imaging were 
excluded and may have contributed to findings that would have led to a different conclusion. 
This point was illustrated in a case study (Hermann & Zabramski, 2007) where two patients 
diagnosed with NASAH had very different outcomes, i.e., one developed vasospasm and 
required 2 weeks in an ICU, whereas the other was discharged home after 5 days.  
Lastly, QoL, performance of activities of daily living (ADLs), and neurological outcomes 
were studied in 26 German patients who had suffered a NASAH from 4 to 69 months earlier 
(Beseoglu et al., 2009). Patients were divided into three groups: perimesencephalic SAH, 
perimesencephalic SAH with intraventricular involvement, and nonperimesencephalic SAH. 
Patients were mailed questionnaires that assessed QoL using the SF-36, ADL performance using 
the Barthel Index, and neurological outcomes by a short neurological status form (no reference 
given).  Of 26 questionnaires mailed, only 19 were returned (9 from Group 1, 4 from Group 2, 
and 6 from Group 3).  Neurologic condition was significantly better in Group 1 (pure 
perimesencephalic SAH) than in Group 3 (nonperimesencephalic SAH, p=0.034), and Groups 2 
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(perimesencephalic SAH + intraventricular hemorrhage) and 3 were not significantly different. 
Patients in Group 3 had longer hospital stays (median= 20.7 days) than in Group 1 (11.2 days).  
Of the 19 patients who returned questionnaires, 2 (11%) had pronounced hemiparesis 
(both from the nonperimesencephalic group) and 1 had mild hemiparesis (from Group 1). All 
patients except the two with hemiparesis had high Barthel Index scores (95-100), indicating 
independence in ADL performance, but these outcomes were not significantly different among 
groups (p=0.364). GOS scores were also good or excellent in all three groups, with no difference 
among groups (p=0.486). Physical functioning (SF-36 scores) decreased in all three groups, but 
did not differ among groups (p=0.709). Patients in Group 1 had normal scores on role 
functioning, with significant reductions in Groups 2 and 3 (p=0.034). General health, particularly 
vitality was reduced in all three groups. Mental health was affected in Groups 2 and 3, 
decreasing their daily activities due to mental or emotional problems (p=0.045 for both items). 
Only 8 of 19 (42%) were able to return back to their jobs (Beseoglu et al., 2009).  
The authors concluded that NASAH is a benign entity (Beseoglu et al., 2009). It may be more 
accurate to label perimesencephalic SAH without intraventricular hemorrhage a benign entity. 
This study clearly demonstrates that role functioning, mental health, and physical health can be 
significantly affected in nonperimesencephalic SAH. The ability to return to work was affected 
in all groups.  However, the results of this study are compromised by the small sample which 
limits the conclusions that authors present, no psychometrics were presented, use of the Barthel 
Index to measure physical disability rather than HRQoL (except for the SF-36) and the wide 
range of time after hemorrhage.   
 
 
 HRQOL in Subarachnoid Hemorrhage Patients 
21 
Conclusion 
      Spontaneous subarachnoid hemorrhage has a high impact on society through loss of 
productive life years (Taylor, 1997). This may be even more significant in the NASAH 
perimesencephalic patient population as they are typically younger in age (Hermann & 
Zabramski, 2007). Knowledge of the disease factors that influence long-term outcomes after 
SAH is clinically important as such factors are possibly modifiable. Information about long-term 
prognosis is essential to patients and their families and has extensive emotional and economic 
consequences (Germano et al., 1998; Hackett & Anderson,2000). Exploring health related 
quality of life is extremely relevant to the NASAH population as existing studies lack consensus 
about whether HRQoL is even affected in NASAH. The five studies on QoL issues in NASAH 
patients also contradict themselves by labeling NASAH as a benign condition, but noting 
multiple HRQoL domains that are affected in these patients. NASAH patients were found to 
have residual complaints of headache, irritability, forgetfulness, depression, weariness, and 
reduced endurance (Greebe & Rinkel, 2007; Marquardt et al., 2000). A recent study confirmed 
that role functioning, mental health and physical health can be significantly affected in non-
perimesencephalic NASAH (58% of NASAH patients were not able to return to work ) 
(Beseoglu et al., 2009).  Understanding what factors cause hardships in patient’s lives would 
mean medical personnel could predict which patients are likely to need more support and require 
specific types of rehabilitation after suffering a NASAH. 
A quantitative survey design study was conducted and to compare health-related quality 
of life (HRQoL) in patients who have experienced a NASAH to that of patients who have 
experienced an ASAH, 1 to 3 years post-hemorrhage. This author hypothesized that if both 
ASAH and NASAH patients are compared on the Hunt and Hess (Hunt & Hess, 1968) grading 
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system (used to classify the severity of a subarachnoid hemorrhage based on the patient's clinical 
condition), Fisher scale (Fisher, Kistler & Davis, 1980) (correlates the location and thickness of 
subarachnoid blood on CT with clinical outcomes), age, and adjusting for other factors will have 
similar HRQoL outcomes.  This knowledge could assist researcher in developing targeted 
interventions that reduce the negative health consequences associated with both NASAH and 
ASAH.  
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 HRQOL in Subarachnoid Hemorrhage Patients 
23 
 
CHAPTER II 
CONCEPTUAL FRAMEWORK 
Introduction 
The framework for this proposed survey design study will be the Conceptual Model of 
Health-Related Quality of Life (Ferrans, Johnson-Zerwic, Wilbur, & Larson, 2005) which is 
based on the Health-related Quality of Life Conceptual Model (Wilson & Cleary, 1995). Using 
the Ferrans model in this study will allow for exploration and understanding of multiple variables 
that affect HRQoL in both NASAH and SAH populations. This chapter will trace the origins of 
QOL that led to the development of the concept health related quality of life (HRQoL), provide 
brief background on the Wilson and Cleary model and then analyze the Conceptual Model of 
Health-Related Quality of Life.  
Quality of Life and Health Related Quality of Life 
“Quality of life” as it applies to healthcare can be traced to the World Health 
Organization (1947) definition of health as a “state of complete physical, mental and social well-
being, and not merely the absence of disease and infirmity.” The psychosocial or quality of life 
variables were introduced to clinical research by Karnofsky and Burchenal (1949) who measured 
cancer patients’ performance status. They described criteria for subjective improvement in what 
is now considered quality of life: “The patient’s subjective improvement is measured or 
described in terms of improvement in his mood and attitude, his general feelings of well-being, 
his activity, appetite, and the alleviation of distressing symptoms, such as pain, weakness and 
dyspnea” (Karnofsky & Burchenal, 1949, pp. 193-194). 
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 In the ensuing 60 years, significant but complicated strides have been made in 
conceptualizing HRQoL and developing tools to measure it. Historically, HRQoL studies have 
been primarily descriptive, providing basic information on psychosocial needs and adjustment of 
various chronic disease populations (Aaronson, 1988). The concept has come into vogue because 
of patients’ extended survival with chronic conditions that were once acute, terminal diseases. 
The number of diseases classified as chronic continues to increase (Murdaugh, 1997).  In the past 
15 years, HRQoL variables such as physical functioning, biological functioning, and general 
perception of well- being have become more important that the medical intervention or cure thus 
more prospective randomized control studies have been completed (Wilson & Cleary, 1995). 
With further use of the concept of HRQoL, confusion resulted. Murdaugh in 1997 first 
discussed the use of multiple definitions and the interchangeable use of similar concepts by 
numerous authors in the HRQoL literature. The complexity continues today with varying 
definitions and instruments making it difficult to conceptualize HRQoL (Ferrans, Johnson-
Zerwic, Wilbur, & Larson, 2005; Sajid, Tonsi & Bang (2008); Spranger & Swartz, 2008)  
A Conceptual Definition of Health-related Quality of Life 
A concept has been defined as a “complex mental formulation of an empirical 
experience” (Chinn & Kramer, 1999, p. 54), an abstract “cognitive representation” of perceptible 
reality formed by direct or indirect experience (Morse, 1995), or a term used to describe a 
phenomenon or a group of phenomena (Meleis, 2007). A concept denotes some degree of 
classification or categorization.  
It is important to briefly define health and quality of life separately. The World Health 
Organization Quality of Life Group (1996) defines health as a state of complete physical, mental 
and social well-being, not merely the absence of disease or infirmity. Health status refers to 
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whether individuals are free from the effects of disease and disability to be able to perform the 
functions they desire and to carry out usual activities required in day-to-day living (Murdaugh, 
1997). Definitions of quality of life are associated with health and personal satisfaction, e.g., “a 
patient's general well-being, including mental status, stress level, sexual function, and self-
perceived health status” (webMD.com, n.d.), and “your personal satisfaction (or dissatisfaction) 
with the cultural or intellectual conditions under which you live (as distinct from material 
comfort)” (dictionary.com, n.d.). 
The health component of quality of life was defined by Ware (1987) as health status. 
Ware defined and measured the components of health status similarly to the commonly described 
domains of quality of life: physical health, mental health, social and role functioning, and general 
perceptions of well-being (Ware, 1987). The term “health status” was also preferred by Bergner 
(1989) instead of quality of life. Health status was described by Bergner (1989) as having six  
dimensions: physical functioning, mental functioning, social functioning, health behaviors, 
attitudes, and genetic foundation. Other conceptualizations of health status contain similar 
domains, with the most commonly reported being physical functioning, psychological 
functioning, and social functioning (Murdaugh, 1997). Similar domains are also used for 
conceptual models of HRQoL (Ferrans, Johnson-Zerwic, Wilbur, & Larson, 2005; Wilson & 
Cleary, 1995). In these models, patient outcomes, including overall HRQOL, are proposed to be 
related to both individual and environmental characteristics. The domain pathways include 
biological function, symptoms, functional status, and general health perceptions. 
These domains of health are also used in definitions of HRQoL. For example, HRQoL is 
defined as encompassing domains of life directly affected by changes in health (Jaschke, Singer, 
& Guyatt, 1989). In the view of these researchers, HRQoL domains are aspects of life that 
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improve when a physician successfully treats a patient. A clinically significant change in HRQoL 
is indicated by a decline in a domain that leads a physician or health care provider to alter a 
medication or medical treatment (Jaschke et al., 1989). 
HRQoL has been formally defined by federal and international agencies. For example, 
the National Library of Medicine (n.d.) defines HRQoL as “Patient outcome measures that 
extend beyond traditional measures of mortality and morbidity to include such dimensions as 
physiology, function, social activity, cognition, emotion, sleep and rest, energy and vitality, 
health perception, and general life satisfaction.” Some of these measures are also known as 
health status, functional status, or quality of life measures (National Library of Medicine). The 
CDC (n.d.) defines HRQoL as referring “to a person or group's perceived physical and mental 
health over time.”  Lastly, the World Health Organization Quality of Life Group (1996) defines 
HRQoL as “an individual’s perception of their position in life in the context of the culture and 
value systems in which they live, in relation to their goals, expectations, standards and concerns. 
It is a broad ranging concept affected in a complex way by the person’s physical health, 
psychological state, level of independence, social relationships and their relationships to salient 
features of the environment.”   
The proposed study will be framed by the Conceptual Model of Health-Related Quality 
of Life (Ferrans et al., 2005). HRQoL is not specifically defined by Ferrans et al. (2005) or by 
Wilson and Cleary (1995), from whose work the Ferrans model is derived. However, HRQoL is 
delineated by what it excludes (Ferrans et al., 2005, p. 336): “this term excludes aspects of 
quality of life that are not related to health, such as cultural, political, or societal attributes. 
Examples are the quality of the environment, public safety, education, standard of living, 
transportation, political freedom, or cultural amenities. Unfortunately, the distinction between 
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health-related and non-health-related quality of life cannot always be clearly made. For example, 
air pollution contributes to chronic respiratory disease, and long dark winters contribute to 
seasonal affective disorder.” Insight into Ferrans’ thinking about HRQoL comes from her early 
definition of quality of life (Ferrans, 1990): an individual’s feeling of satisfaction or 
dissatisfaction with significant domains of his her life.  
After extensive research on quality of life, Ferrans (1997) proposed that a concept in 
general may not be synthesized into a coherent whole. It is generally agreed that HRQoL is a 
multidimensional concept (Murdaugh, 1997). However, despite an extensive literature review no 
commonly accepted definition could be found for HRQoL, and usually only operational 
definitions are provided as evidence of its domains. 
Operational Definition of Health-related Quality of Life 
 As mentioned above, this study used the Conceptual Model of Health-Related Quality of 
Life (Ferrans et al., 2005), which is based on the Health-related Quality of Life Conceptual 
Model (Wilson & Cleary, 1995). For this study, the operational definition of HRQoL was based 
closely on both models’ terminology and conceptualized relationships. Health-related quality of 
life is defined as an individual’s feeling of well-being derived from such dimensions as biologic 
function, symptoms, functional status, health perception, and overall quality of life as influenced 
by attributes of one’s developmental, psychological and environmental characteristics. 
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Figure 1. Relationships among measures of patient outcome in a health-related quality of 
the conceptual model from “A conceptual model of practice outcomes. Linking 
clinical variables with health-related quality of life: ” by Wilson, I. B. & Cleary, 
P. B. (1995) p 61  JAMA Reprinted with permission from JAMA 
The Wilson & Cleary (1995) model (Figure 1) uses measures of health that exist on a 
continuum of biological/physiological, psychological, social complexities forming causal 
pathways between each other and other concepts such as symptoms, functioning, general health 
perceptions and overall quality of life. The pathways do not apply a hierarchal order of 
importance. As one moves from left to right in the model, one moves outward from the cell to 
the individual to the interaction of the individual as a member of society. The goal of the Wilson 
and Cleary (1995) model was to help clinicians and researchers test causal relationships and 
provide effective patient outcomes. Wilson & Cleary use the term quality of life and health 
related quality of life interchangeably. The Wilson & Cleary model has been tested in a number 
of populations including heart failure Bennett et al., (2001), cancer Wettergren, Bjorkhom, 
Axdorph & Languis-Eklof (2004), HIV Sousa, Holzemer, Henry, & Slaughter, (1999) and 
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Parkinson’s disease Chrischilles, Rubenstein, Voelker, Wallace & Rodnitzky, (2002). 
populations. In these studies the Wilson and Cleary model provided predictive values in the 
majority of the HRQoL domains. Bennett et al. found that social support were significant 
predictors of changes in health-related quality of life. Sousa et al. (1996) found that the model 
predicted 32% of variance in overall quality of life particularly in the symptom domain. 
Wettergren et al. and Churchilles et al. used the model to direct their choice of study design, 
research instruments, and rehabilitation program for patients with lymphoma and Parkinson’s 
disease. The Wilson and Cleary model has provided clinicians a useful model that integrates both 
medical and social sciences paradigms to fully examine HRQoL. Ultimately, the Ferrans model 
(Ferrans et al., 2005) was chosen to guide my proposed study as it provided a structure that can 
guide researchers with consistent definitions and clarification of relationships which will lead to 
appropriate choices of measurement tools for this study. However, the major tenants of the 
Ferrans model are based solely on Wilson & Cleary’s model.  
 
Figure2. Revised Wilson and Cleary model for health related quality of life from 
“Conceptual Model of Health-Related Quality of Life” by Estwing- Ferrans, C., Johnson 
Zerwic, J. Wilbur, J.E.,& Larson, J. L. (2005) Journal of Nursing Scholarship, 37, p344. 
Reprinted with permission from the Journal of Nursing Scholarship. 
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The Ferrans model (Ferrans et al., 2005) (Figure 2) is specifically designed to connect 
specific clinical factors in each domain to HRQoL. Using the Ferrans model in this study 
allowed for exploration and understanding of multiple variables that affect HRQoL in both 
NASAH and SAH populations. Prior to developing this model, Ferrans and her colleagues 
(Ferrans, 1997; Ferrans & Powers, 1992) developed the concept of quality of life (QOL) using 
several different research approaches to refine a conceptual model. To clarify the concept of 
QOL across cultures, Ferrans (1997) used qualitative research methods to determine the 
indicators associated QOL.  QOL was also analyzed by factor analysis techniques to find clusters 
among its various domains (Ferrans & Powers, 1992). This information was used to develop a 
tool, the Quality of Life Index, to operationalize the concept of QOL and its dimensions (Ferrans 
& Powers, 1992). Ferran (p 336) does not provide an operational definition but defines what 
HRQoL is not “This term excludes aspects of quality of life that are not related to health, such as 
cultural, political, or societal attributes.” The domains of HRQoL in this model were based on 
the defining work of Wilson and Cleary (1995), and expanded with multiple layers of influence 
from individual and environmental characteristics from earlier ecological models (Eyler et al., 
2002; McLeroy, Bibeau, Steckler, & Glanz, 1998). These ecological models not only provide 
empirical support for Ferran’s modifications of the Wilson and Cleary model, but also emphasize 
the role of factors outside the individual that influence behavior.  Ferrans et al.’s (2005) model is 
modified the Wilson and Cleary (1995) model to provide a logical direction and form of the 
relationships between HRQoL domains. Specifically, the original model was revised in three 
substantive ways: (a) by adding arrows to show that biological function is influenced by 
characteristics of both individuals and their environment, (b) by deleting nonmedical factors, and 
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(c) by deleting labels on arrows since they restricted characterization of those relationships 
(Ferrans et al., 2005).  
Lastly, in choosing a model to guide this study the author wanted one that had been used 
in a population similar to my target population, NASAH patients, since neurological patients 
may have cognitive deficits and their own set of complexities, requiring specific instruments to 
measure HRQoL (Daggett et al., 2009). The Ferrans et al. (2005) model has been used to frame a 
meta-analysis of adult traumatic brain injury survivors and found to clearly define and 
encompass the domains of HRQoL relevant to these patients (Daggett et al., 2009).  
Operational Definitions 
 The operational definition of HRQoL used in this study was closely based on the 
terminology and conceptualized relationships of the HRQoL model proposed by Ferrans and 
colleagues (Ferrans, Zerwick, Wilbur, & Larson, 2005). In that model, health-related quality of 
life is defined as an individual’s feeling of well-being in five domains biologic function, 
symptoms, functional status, general health perception, and overall quality of life. Each domain 
is influenced by one’s individual and environmental characteristics. The five HRQoL domains 
and two sets of influential factors, which will be measured in NASAH patients, are defined 
below.  
Biological function. This domain encompasses the “dynamic processes that support life,” 
e.g., molecular, cellular and whole organ-level processes (Ferrans et al., 2005, p. 338). Biologic 
factors in SAH include brain functions, physical and psychological capabilities such as 
memory/cognition, hemiplegia or paresis and depression, which might be permanently changed 
in the NASAH patient population due to SAH. This domain should also include family history 
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(genetic predisposition) as having a first-degree relative with SAH has been linked to up to seven 
times higher risk for SAH than the general population (Bromberg et al., 2005).   
Symptoms. Symptom status will be defined by participants’ perceptions of physical, 
psychological, or psychophysical symptoms. Symptoms are commonly measured in terms of 
frequency, intensity, and distress using global, condition-specific, and symptom-specific 
instruments (Ferrans et al., 2005). Measuring symptoms with a condition-specific instrument is 
suggested by Ferrans et al. (2005). SAH symptoms may include short-term memory loss, 
weakness in one or more extremities, and anxiety.  
Functional status.  This variable is broadly defined as the ability to care for or perform 
one’s social/role and psychological functions (Ferrans et al., 2005). This variable may be 
measured in NASAH patients as either decreased physical endurance/strength or cognitive 
function/memory. 
General health perception. This variable is defined as participants’ perceived overall 
health, which Ferrans et al. (2005) recommend measuring with the Medical Outcomes Study 
Short Form questionnaire (SF-36).  
Overall quality of life. This variable is defined as participants’ subjective well-being 
derived from all domains of HRQoL. 
Individual characteristics.  These characteristics are categorized as “demographic, 
developmental, psychological and biological factors that influence health outcomes” (Ferrans et 
al., 2005, p. 337). 
Environmental characteristics.  These characteristics are categorized as social (family 
or friends) or physical environmental (home, work place, or neighborhood) factors that influence 
health outcomes (Ferrans et al., 2005). 
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Summary 
The Ferrans et al. (2005) model provides a sound conceptual framework which will help 
delineate the factors that can affect HRQoL in NASAH. The Ferrans model builds on a prior 
model, provides a theoretical basis, and has been used in a neurological patient population. The 
Conceptual Model of Health-Related Quality of Life (Ferrans et al., 2005) is an appropriate 
framework for examining the effects of a SAH and NASAH on HRQoL. 
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Chapter III 
 Methods 
Introduction 
A quantitative survey design study was proposed to compare health-related quality of life 
(HRQoL) 1 to 3 years post-hemorrhage in patients who have experienced a NASAH and in those 
who have experienced an ASAH. This author hypothesized that both ASAH and NASAH 
patients would have similar HRQoL outcomes when controlling for the influence of age, relative 
time since hemorrhage, and score on the Fisher scale (Fisher, Kistler & Davis, 1980).  The Fisher 
scale correlates the location and thickness of subarachnoid blood on CT with clinical outcomes. 
This knowledge could assist researchers in developing targeted interventions that reduce the 
negative health consequences associated with NASAH.  
Purpose Statement 
The purpose of this quantitative survey design study was conducted to compare health-
related quality of life (HRQoL) 1 to 3 years post-hemorrhage in patients who experienced a 
NASAH to those who experienced an ASAH.  
Specific Aims 
1. To describe the physical, psychological, social, and vocational impact of nonaneurysmal and 
aneurysmal subarachnoid hemorrhage on patients at 1 to 3 years post-hemorrhage.  
2. To examine differences in HRQOL between patients with NASAH and ASAH after 
controlling for severity of hemorrhage, age, and time since event.   
3. To examine the effects of employment status, PTSD, and social support (by adjusting for each 
variable) on HRQOL for patients with NASAH and ASAH and determining if the adjustment 
accounts for any HRQoL differences between NASAH and ASAH patients.  
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4. To describe management strategies used by patients with nonaneurysmal and aneurysmal 
subarachnoid hemorrhage that helped improve their HRQoL. 
Design  
This study used a quantitative design that focused on objectivity, control, precise 
measurement, and quantification of data to describe, predict, or determine cause-and-effect 
relationships (Whitmore & Melkus, 2008). Specifically, a survey design was used to examine 
and compare the relationships among HRQoL, clinical outcomes, and patient demographics in 
both NASAH and ASAH patients.  
Sample and Setting  
The NASAH population is extremely small, consisting of 15% (range 5-34%) of patients 
with nontraumatic SAH where no source of hemorrhage can be identified via four-vessel 
cerebral angiography (Alen et al., 2003; Gupta et al., 2009). Prior studies with NASAH subjects 
have included 19-160 subjects (Beseoglu et al., 2009 N= 19; Gupta et al., 2009 N=34; Greebe & 
Rinkel, 2007 N=160; Marquardt, Niebauer, Schick, & Lorenz, 2000 N=160; Brilstra, Hop, & 
Rinkel, 1997 N=25). Men and woman with NASAH were recruited from Beth Israel Deaconess 
Medical Center (BIDMC), from a database of 320 SAH patients were treated between 2006 and 
2010.  
Power analysis – A power analysis for Aim # 3 was conducted:  To examine the effects of 
employment status, PTSD, and social support (by adjusting for each variable) on HRQOL for 
patients with NASAH and ASAH and determining if the adjustment accounts for any HRQoL 
differences between NASAH and ASAH patients. Using an alpha level of 0.05, 7 predictors, effect 
size of .20 and 80 subjects demonstrated a power of .89.   
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Participants for this study were initially recruited via mail from SAH patients in the 
BIDMC database. To comply with Health Insurance Portability and Accountability Act (HIPAA) 
regulations, a letter on BIDMC letterhead was mailed to these patients’ last known home address 
informing them of the purpose of the study and requesting them to participate in the study with 
attached to the instrument package. A self-addressed stamped envelope was enclosed for their 
response. Potential subjects were also given an e-mail address and telephone number to reach the 
PI if they had a question or preferred to contact the PI directly. They were asked to return a blank 
packet if they did not want to participate in the study.  Patients who did not contact the principle 
investigator within 3 weeks received a reminder card by mail. Three weeks from the reminder 
card mailing a second complete mailing was sent. After the three non-responses, we assumed the 
the subject did not want to participate.  
 Inclusion/Exclusion criteria. Participants were required to satisfy the following 
inclusion criteria: (a) diagnosed with nontraumatic SAH and two diagnostic cerebral angiograms 
negative or positive for aneurysm (Alen et al., 2003), (b) diagnosed with NASAH or ASAH 
more than 1 year, but not more than 3 years from data collection, (c) free from any physical 
disability unrelated to ASAH or NASAH, (d) > 18 years old (to provide informed consent), (e) 
mentally capable of giving informed consent (determined by their ability to contact the 
investigator to participate in the study, following the study directions, complete the questionnaire 
items and return the questionnaire in the self-addressed envelope), (f) able to read and speak 
English. 
Instruments 
The study variables were measured using six instruments: the Stroke-Specific Quality of 
Life scale (SS-QOL; Williams, Weinberger, Harris, Clark, & Biller, 1999), 12-Item Short Form 
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Health Survey (SF-12; Ware, Kosinski, & Keller, 1996), Duke–UNC Functional Social Support 
Questionnaire (FSSQ; Broadhead, Gehlbach, DeGruy, & Kaplan, 1988), a researcher-developed 
NASAH-specific questionnaire for effects on HRQoL, a researcher-developed demographic 
questionnaire (Table 2) and a PTSD scale by the Trauma Awareness & Treatment Center 
(TATC) was used to explore the issue of PTSD. Each instrument is described in detail below.  
Table 1  
Alignment of Domains of HRQoL, Instruments to Measure Domains, and Study Aims 
Domain Instrument Study Aim 
Biological function SF-12 1,2 
Symptoms SF-12 1,2 
Functional Status SS-QOL 1,2,3 
General Health Perception SF-12 1,2 
Overall Quality of Life SS-QOL/SF-12 1,2 
Individual Characteristics Demographic Information 
NASAH-Specific Questionnaire  
1,2,3 
Environmental Characteristics Demographic Information 
NASAH-Specific Questionnaire 
Duke–UNC Functional Social 
Support Questionnaire (FSSQ) 
1,2,3 
 
SS-QOL. The SS-QOL is a validated, patient-centered outcome measure that holistically 
assesses health-related quality of life specific to patients with stroke (Williams et al., 1999). This 
instrument was chosen instead of the Quality of Life Index (QLI; Ferrans & Powers, 1985), 
which was first considered since it was developed by the author of the proposed study’s 
framework. However, the QLI was not consistent with this study’s aims and was less specific 
than the SS-QOL for the domains affected by SAH. 
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An initial pool of 78 items was developed for the SS-QOL from interviews with ischemic 
stroke survivors (Williams et al., 1999). Psychometric analysis of these items led to a final pool 
of 49 items grouped into 12 domains: mobility, energy, upper extremity function, 
work/productivity, mood, self care, social roles, family roles, vision, language, thinking, and 
personality.  The SS-QOL is scored, as an unweighted average of domain scores and ranges from 
1.0 (worst) -5.0 (best). Domain scores are unweighted averages of the individual items in that 
domain and also range from 1.0 – 5.0. responses rated. The 5-point Likert scale response options 
range from1 (total help/couldn’t do it at all/strongly agree) to 5 (no help needed/ no trouble at 
all/strongly disagree).  The scores are averaged item ratings; they tend to have a normal 
distribution and can be analyzed as a continuous variable.  
The internal consistency reliability (Cronbach's alpha) of the SS-QOL in 34 individuals 
with stroke ranged from adequate (alpha = 0.75 for work/productivity subscale) to excellent 
(alpha = 0.89 for self-care), suggesting strong internal consistency (Williams et al., 1999). The 
SS-QOL had excellent 2-week test-retest reliability (r = 0.92) when administered by a trained 
interviewer to 47 stroke survivors (Williams et al., 2000). The SS-QOL also showed excellent 
inter-rater reliability (r = 0.92) when administered 2 hours apart by two different trainers 
interviewers to 24 stroke survivors (Williams et al., 2000). In 141 ASAH patients, the SS-QOL 
showed good internal consistency reliability for all 12 domains (alphas >.80) (Boosman Passier, 
Visser-Meily, Rinkel, & Post, 2009). 
All SS-QOL domains have been shown to be unidimensional, with good internal 
reliability (Cronbach’s alphas > .73), excellent test-retest and inter-rater reliability (alphas > .92 
for overall and individual domain scores), and to have good construct and known-groups validity 
(Williams et al., 1999).  In addition to the 49 items used in scoring, 13 items at the end of the 
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questionnaire can be used to categorize how much the stroke affected each domain and overall 
quality of life. These items will be used to assess the subjects perception of how their quality of 
life has been altered since their subarachnoid hemorrhage.  
In this study, the SS-QOL was completed by self-report. However, the reliability and 
validity of self-report administration of the SS-QOL has not been previously reported.  
Therefore, this approach was pilot tested in 2 patients and the reliability of the SS-QOL was 
evaluated for the total study sample. Permission to use this instrument has been granted by Dr. 
Linda Williams, author of the SS-QOL. 
SF-12. This instrument was developed for the Medical Outcomes Study, a multi-year 
study of patients with chronic conditions (Ware et al., 1996). The short-form survey instrument 
was designed to reduce respondent burden while achieving minimum standards of precision for 
group comparisons involving multiple health dimensions. The SF-12 includes a subset of 12 
items from the SF-36 and was developed for applications where two summary scores (physical 
health [Physical Component Summary] and mental health [Mental Component Summary]) might 
be sufficient (Ware et al., 1996). The SF-12 was designed to measure general health status from 
the patient's point of view. The SF-12 includes 8 concepts commonly represented in health 
surveys: physical functioning, role functioning physical, bodily pain, general health, vitality, 
social functioning, role functioning emotional, and mental health.  
The 12-item Physical Component Summary and 12-item Mental Component Summary 
showed excellent to good 2-week test-retest reliabilities (r=0.89 and 0.76, respectively) in the 
general US population (n=232) (Ware et al., 1996). These summary scales also showed adequate 
to excellent validity in tests comparing the SF-12 to the SF-36. The alphas for 12-item Physical 
Component Summary ranged from 0.43 to 0.93 (median=0.67) in 14 relative validity tests that 
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compared the SF-12 and SF-36. Alphas for the Mental Component Summary ranged from 0.60 
to 1.07 (median=0.97) in 6 tests involving mental criteria that compared the SF-12 and SF-36 
(Ware et al., 1996).  
The SF-12 has not been tested in SAH patients, but the SF-36 has been found to be 
reliable in numerous studies on SAH patients (Katai et al., 2007; Kim, Haney, & Van Ginhoven, 
2005; Noble & Schenk 2010; Sharbrodt et al., 2009). Each study recommended using the SF-36 
as part of assessment outcomes as it was better at predicting long-term outcomes than other 
instruments such as the Barthel Index, National Institutes of Health Stroke Scale, Rankin scale, 
and Glasgow Outcomes scale (Kim, Haney, & Van Ginhoven, 2005; Scharbrodt et al., 2009).  
The SF-12 was mailed to participants for self-completion. The SF-12 has been validated 
to use as a self-administered instrument (sf-36.org). Permission to use the SF-12 was granted 
from QualityMetric Health Outcomes.  
Duke-UNC Functional Social Support Questionnaire (FSSQ) This instrument was 
used to measure a subject’s perception of the amount and type of personal social support they 
have received since their subarachnoid hemorrhage. The instrument takes 5 minutes to complete 
and it may be self administered (Broadhead, Gehlbach, DeGruy, & Kaplan, 1988). Internal 
consistency for this instrument is excellent (Cronbach’s alpha .81 - .92) across racial groups and 
study sites and data points (Bellon Saameno, Delgado Sanchez, Luna del Castillo & Lardelli 
1996).  The FSSQ  item response options are on a 5-point scale ranging from 1 (much less than I 
would like) to 5 (as much as I would like). Higher scores reflect higher perceived social support.  
The PTSD Questionairre. The PTSD questionnaire is adapted from the Trauma 
Awareness & Treatment Center (TATC). Permission to use was granted by Dr Larry Beall who 
is the director of the program. He is unaware of the exact origin of the scale. In researching other 
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PTSD scales it appears to be very similar to the Trauma Screening Questionnaire (TSQ) 
(Brewin, Rose, Andrews, Green, Tata, McEvedy & et al., 2002). Both scales consist of 10 
questions, 5 of which are the exact same questions and the remainder questions have similar in 
content. The TSQ items are derived from from DSM-IV criteria and describe either re-
experiencing symptoms or avoidance and numbness symptoms (Brewin et al., 2002). 
Psychometric data from two samples indicated for PTSD screening purposes, the TSQ enables 
excellent levels of prediction when measuring symptoms sensitivity, specificity, positive 
predicative and negative predicative power. The TATC PTSD questionnaire was chosen over the 
TSQ as the questions were more appropriate for a population who has suffered a medical trauma 
rather than a violent event. The TATC PTSD questionnaire is short contains items necessary to 
for accurate PTSD diagnosis and it is written in simple language.  
SAH-specific questionnaire on HRQoL. In order to provide a more specific 
understanding of the long-term effects of NASAH and ASAH on HRQoL, participants self-
administered a researcher-developed questionnaire (Table 2). The questionnaire items are 
aligned with the study aims to gain information that might be used in future interventions with 
the NASAH population.  
 
 HRQOL in Subarachnoid Hemorrhage Patients 
42 
Table 2 SAH-Specific Questionnaire on HRQoL  
Aim Question 
1. To describe the physical, 
psychological, social, and 
vocational impact of 
nonaneurysmal and aneurysmal 
subarachnoid hemorrhage on 
patients at 1 to 3 years post-
hemorrhage.  
3. To examine the effects of 
employment status, PTSD, and 
social support (by adjusting for each 
variable) on HRQOL for patients 
with NASAH and ASAH and 
determining if the adjustment 
accounts for any HRQoL differences 
between NASAH and ASAH 
patients.  
 
1. Were you employed before your SAH? 
2. If yes, have you returned to your position or 
equivalent position? 
3. If no, do you feel your inability to return to prior 
or equivalent position is related to your SAH? 
4. Have you been denied any type of health or life 
insurance because of your SAH? 
2. To examine the effects of symptom 
status, functional status, and 
support (psychological, economic, 
and social) on HRQoL of these 
patients.  
1. Do you feel your overall quality of life has been 
affected by SAH? 
2. Do you suffer specific physical, emotional, or 
psychological symptoms as a direct result of 
your SAH? If so, please list the symptoms 
4. To describe management strategies 
used by patients with 
nonaneurysmal and aneurysmal 
subarachnoid hemorrhage that 
helped improve their HRQoL. 
 
1. Did you receive outpatient physical therapy as a 
result of your SAH? If so, for how long? 
2. Did you receive outpatient occupational therapy 
as a result of your SAH? If so, for how long? 
3. Did you receive outpatient speech therapy as a 
result of your SAH? If so, for how long? 
4. Did you need any psychological therapy after 
SAH? If so, for how long? 
5. Did you use or receive a treatment/procedure 
that helped your recovery from SAH? 
6. Is there any type of service you wish you had 
available to you during your recovery? 
 
 
Demographic questionnaire. Study participants were asked to indicate their age, gender, 
race, education level, marital status/support systems, use of alcohol/tobacco, and family history 
of SAH. Epidemiological factors such as cigarette smoking, alcohol consumption, hypertension, 
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and family history of SAH are all independent risk factors of SAH (Juvela, 2002). Beseoglu, 
Pannes, Steiger & Hanggi (2009) have found a correlation between hypertension and smoking in 
the NASAH population.  PTSD has been found to occur in the subarachnoid hemorrhage 
population and was recently recommended as area that needs further research in this population 
(Noble & Schenk, 2010 ) A simple 10 question PTSD scale by the Trauma Awareness & 
Treatment Center (TATC) will be used to explore the issue of PTSD further in this population.  
Survey Design 
 Survey methodology is used to measure variables by asking people questions and then to 
examine relationships among the variables. In this study the surveys attempted to capture health 
related quality of life after a subarachnoid hemorrhage.  
 A recent meta-analysis by Noble & Schenk (2010) studied variables to explain poor 
health related quality of life after SAH. Twelve articles were examined, using the predictor 
patient age, sex of patient, clinical severity, bleed severity and cognitive impairment. Only the 
variable of physical disability (effect size .54) was found to be a useful predictor of poor 
HRQoL. Age also needs to be considered as a predictor value with an effect size of .20. The 
traditional variables cited in other studies such as sex, severity of bleed, clinical severity of bleed 
at the time of admission to the hospital, time between SAH and assessment of HRQoL  have only 
minimal effects on patients’ physical and mental HRQoL. This study examined the HRQoL 
outcomes for both ASAH and NASAH and examine their differences by controlling for size of 
hemorrhage, distinguishing between perimesencephalic and non-perimesencephalic bleeding 
pattern, age, time since event in multivariate analyses.  
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Procedures 
 All procedures related to this study were approved by the BIDMC IRB and UMMS IRB.  
All subjects that met inclusion criteria were mailed a packet with the following items: cover 
letter, demographic questionnaire, SS-QOL, SF-12, FSSQ, PTSD questionairre and SAH-
specific questionnaire. If subjects chose not to participate (mentioned in the cover letter) they 
were instructed to return a blank questionnaire in the self-addressed envelope.  These subjects 
did not receive any additional mailings. The subjects were provided a phone number to contact 
the principal investigator to clarify questionnaire items or address any concerns related to the 
items. If needed, the principal investigator offered to arrange appointments with neurosurgeons, 
neurologists, physical therapists, and occupational therapists at BIDMC. Three weeks later, a 
follow-up reminder card was mailed to participants. Two weeks later, a second complete mailing 
with an instrument package was sent to those who had not yet responded. Thank you notes and 
$5 gift cards were sent within one to two week from the time a returned package was received.    
Data Management – Prior to the mailings the instrument packets each subject’s packet were 
coded with a unique research number. A list of the subjects’ names and contact information and 
the unique ID number were kept in a locked drawer in the PI’s office.  This list was destroyed 
once the final statistical procedures were completed. The paper packets were locked in a file 
cabinet at BIDMC. Once returned packets were received the data were entered into the SPSS 
data base created for this study was managed through a secure drive to store de-identified data in 
the form of SPSS. The SAH-Specific Questionnaire on HRQoL and Demographic Questionnaire 
were analyzed via SPSS to yield appropriate descriptive statistics (mean, standard deviation, 
percentages). SPSS was used for scoring the SS-QOL. Scores were computed for the overall SS-
QOL or as well as individual domain scores. According to SSQOL administrative guide, missing 
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items are handled in the following way: if more than half of the items in a given domain are 
missing that domain is not scored and the resulting overall SS-QOL score is an average of the 
remaining domain scores. If less than half of the items in a given domain are missing, the scored 
items are averaged and rounded to the nearest integer. This imputed item score is then substituted 
for the missing item(s).   
The SF-12 results were expressed in terms of two meta-scores: the Physical Component 
Summary (PCS) and the Mental Component Summary (MCS). The SF-12 is scored so that a 
high score indicates better physical functioning. All 12 questions have a specific standardized 
value for each item response In order to convert each item response into both physical and 
mental standardized values according to a SF-12 conversion table (sf-36.org, 2010). Those 
numbers are then summed, the physical standardized values across all 12 items and add 56.57706 
to create the SF-12 PCS score (sf-36.org, 2010). The mental standardized values are summed in a 
similar fashion and add 60.75781 to create the SF- 12 MCS score. The mean=50, SD=10 in the 
1998 general U.S. population that has made scales and summary measures easier to interpret for 
the SF-12Health Survey (sf-36.org, 2010). QualityMetrics provided a database to score all our 
SF-12 questionnaires.  
The PCS and MCS scores have a range of 0 to 100 and were designed to have a mean 
score of 50 and a standard deviation of 10 in a representative sample of the US population (sf-
36.org, 2010). Scores greater than 50 represent an above average health status. Scores of subjects  
with a score of 40 function at a level lower than 84% of the population (one standard deviation) 
and people with a score less than 30 function at a level lower than approximately 98% of the 
population (two standard deviations). Since the SF-12 PCS and MCS scores are directly 
weighted functions of SF-12 items, the amount of missing data will have a significant impact on 
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the imputed value. As the number of missing SF-12 items increases, the available information 
and predicting power from SF-12 items diminishes. The QualityMetric Incorporated’s MDE 
software algorithms reduced the bias in estimates of missing responses, and made it possible to 
compute scale and summary scores for many respondents who would have otherwise been lost 
due to missing data (sf-36.org, 2010).  
Data Analysis The primary research question and specific aims were answered separately using 
SPSS version 19 and specific scoring information for the SSQoL and SF-12.  Descriptive 
statistics were used to provide a general understanding of the population through the 
demographic questionnaire. The PTSD questionnaire and FSSQ only required simple addition to 
determine if PTSD and social support were present.  
The first step was to print the data file and cross check the data from the original instruments. 
All errors found were corrected. The distributions were examined along with analysis of the 
frequencies for each variable. Missing data were examined and specific instrument instructions 
were followed as to whether the subject’s data can be used if missing data were found. The 
reliability of the instruments was calculated to determine the cronbach’s alphas.  The value was 
compared to other studies that have used these instruments. This was particularly important for 
the SS-QOL which has not been tested as a self-administered instrument in the past. Lastly there 
was a need to transform data that did not meet the assumptions of parametric analysis. The 
assumptions of parametric analysis were assessed using tools such as histograms, scatterplots 
and boxplots.  
For the first specific aim (To describe the physical, psychological, social, and vocational 
impact of nonaneurysmal and aneurysmal subarachnoid hemorrhage on patients at 1 to 3 
years post-hemorrhage) descriptive statistics, including Mean, Median, Standard Deviation 
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were used to describe the physical (SS-QOL/SF-12), psychological (SS-QOL/SF-12), social 
(SS-QOL/SF-12/Demographic Questionnaire and Subarachnoid  Questionnaire on HRQoL) 
and vocational impact (NASAH-Specific Questionnaire on HRQoL ) of the study participants. 
The scores of the SSQoL and SF-12 were compared using two sample independent t-tests or 
Mann Whitney tests depending on the distribution. For the second specific aim (To examine 
differences in HRQOL between patients with NASAH and ASAH after controlling for severity 
of hemorrhage, age, and time since event )and third specific aim (To examine the effects of 
employment status, PTSD, and social support (by adjusting for each variable) on HRQOL for 
patients with NASAH and ASAH and determining if the adjustment accounts for any HRQoL 
differences between NASAH and ASAH patients.) table 3 describes the statistical procedures to  
used based on the level of measurement for each part of both aims. A p < .05 was considered 
significant. Note employment status was measured by inability to return to work or to 
equivalent position due to subarachnoid hemorrhage as a dichotomous outcome.  
Table 3 Statistical Procedures for Aim 2 and 3 
Level of Measurement for outcome variables Statistical Procedure Used 
SF-12 (symptom status) 
Interval  scale 
ANCOVA/linear regression 
SS-QOL (functional status) 
Interval scale 
ANCOVA/linear regression 
SS-QOL/SF-12/ FFSQ/PTSD/Demographic 
Questionnaire and SAH-Specific 
Questionnaire on HRQoL  
(Nominal and interval scales) 
Logistic regression  
ANCOVA/linear regression 
Binomial logistic regression 
Descriptive Statistics with linear regression  
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For the fourth specific aim (To describe management strategies used by patients with 
nonaneurysmal and aneurysmal subarachnoid hemorrhage that helped improve their 
HRQoL.) Very few subjects answered these questions so the management strategies were 
combined into like categories and percentage of responses were calculated and compared 
between those with ASAH and NASAH.  
Conclusion 
 The quantitative survey design was chosen to study the NASAH population. This study  
examined the HRQoL outcomes for both ASAH and NASAH and examined their differences by 
controlling for size of hemorrhage, distinguishing between perimesencephalic and non-
perimesencephalic bleeding pattern, age, time since event in multivariate analyses.  
Approximately 109 SAH subjects were available at BIDMC to be considered as potential 
subjects for matching for the years 2006-2010.  
The instruments were chosen to align with the study aims and the domains of the study 
framework (Ferrans et al., 2005). Subjects were recruited by mail and self-administered 
instruments sent by mail. Respondent burden was minimized by using instruments (the SS-QOL, 
SF-12, demographic and NASAH-specific questionnaires) that can be completed in 30-35 
minutes. The SS-QOL was validated for self-completion. Factors influencing NASAH patients’ 
experiences of HRQoL issues were determined and compared to an adjusted to those of ASAH 
patients. 
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Chapter IV 
Results 
Introduction 
This chapter presents the results of the pilot study, descriptive data on subjects’ 
characteristics, and regression analyses. Regression models were designed to address the specific 
aims. The chapter also presents subjects’ responses to open-ended questions, reliabilities 
(Cronbach’s alphas) of instruments used to collect data, and comparison of these reliabilities 
with those from previous studies using the same instruments.   
Pilot Study 
A pilot study was conducted with 5 ASAH subjects (due to the limited number of 
NASAH subjects) to assess three survey characteristics: (1) response time to return the surveys, 
(2) completeness of surveys returned, and (3) test procedures. Of five instrument packages 
mailed, two were returned and required no modifications as both were thoroughly completed.  
Results of the pilot study indicated dysfunction in both the physical and emotional domains. 
Both subjects had aneurysmal hemorrhages approximately 24 months since the event. They had 
moderate levels of PTSD and high levels of social support.   
Sample Selection 
Subjects were identified by diagnosis-related group (DRG) category 430 (subarachnoid 
hemorrhage). Of 360 potential subjects identified, 109 met the selection criteria (Figure 1). 
Common reasons for the 251 subjects excluded included: traumatic subarachnoid hemorrhage or 
no subarachnoid hemorrhage, only one diagnostic cerebral angiogram performed, English was 
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not primary language spoken. Surveys were mailed to these 109 eligible subjects, of whom 65 
returned surveys; seven surveys were undeliverable. Of the 65 returned surveys, three were not 
completed (subjects declined to take the survey), and two could not be used (subjects could not 
be identified and categorized). Thus, the overall response rate was 59%. The final number of 
subjects was 60, of whom 35 (58%) were aneurysmal and 25 (41%) were nonaneurysmal. This 
distribution of type of hemorrhage (aneurysmal versus nonaneurysmal) is consistent with the 
usual population of subarachnoid hemorrhage patients at Beth Israel Deaconess Medical Center. 
From 2006 to 2010, 37% of patients were nonaneurysmal subarachnoid hemorrhage patients. 
Figure 3 
Flow Diagram of Sample Selection 
 
 
 
 
 
 
Assessed for eligibility, 
N=360 
Excluded, 
n=251 
Met criteria, n=109  
Returned surveys, n=65 
• Declined to participate via 
returned survey, n=3 
• Unable to categorize subject 
due to missing data, n=2 
Nonaneurysmal, n=25 
Final sample, n=60 
Aneurysmal, n=35 
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Subject Characteristics 
The demographic and clinical characteristics of subjects classified as aneurysmal versus 
nonaneurysmal are shown in Table 4.  These two groups did not differ significantly by gender, 
race, education, relationship status, alcohol/smoking use, insurance denial, physical or emotional 
symptoms, or perceived quality of life after subarachnoid hemorrhage.  However, they did differ 
by Fisher grade, employment, as well as participation in physical therapy (PT) and occupational 
therapy (OT). Aneurysmal patients had significantly greater Fisher grade scores than 
nonaneurysmal patients. This difference was expected given that intraparenchymal and 
intraventricular blood can occur as part of aneurysmal rupture. Due to the large size of these 
hemorrhages, aneurysmal patients generally have more physical disability and require physical 
and occupational therapy, explaining the significant difference in PT and OT participation in 
these groups. Only 52% of nonaneurysmal patients remained employed in the same position post 
subarachnoid hemorrhage versus 63% of aneurysmal patients (p=.033).  
Table 4  
Demographic and Clinical Characteristics by Type of Subarachnoid Hemorrhage 
Characteristic 
Aneurysmal Nonaneurysmal Total 
n % n % N % 
Fisher Grade (Fisher’s exact=0.027)       
<1 mm thick or none 1 2.90 3 12.00 4 6.70 
>1 mm thick 10 28.60 13 52.00 23 38.30 
Parenchymal /IVH 24 68.60 9 36.00 33 55.00 
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Characteristic 
Aneurysmal Nonaneurysmal Total 
n % n % N % 
Gender (Pearson chi2(1) = 0.3801 P = 
0.538)       
Male 14 40.00 12 48.00 26 43.30 
Female 21 60.00 13 52.00 34 56.70 
Race (Fisher’s=1.000)       
American Indian 1 2.90% 0 0.00 1 1.70 
Asian 1 2.90 0 0.00 1 1.70 
Black or African American 1 2.90 0 0.00 1 1.70 
Hispanic 1 2.90 1 4.00 2 3.30 
White 30 85.70 23 92.00 53 88.30 
Other 1 2.90 1 4.00 2 3.30 
Education (Fisher’s=0.123)       
Some high school 5 14.30 0 0.00 5 8.50 
High school graduate 13 37.10 6 25.00 19 32.20 
Associate degree 4 11.40 4 16.70 8 13.60 
Bachelor degree or higher 13 37.10 14 58.30 27 45.80 
Relationship status (Fisher’s=0.506)       
Single 7 20.60 2 8.00 9 15.30 
Married 20 58.80 18 72.00 38 64.40 
Divorced 5 14.70 3 12.00 8 13.60 
Widow 0 0.00 1 4.00 1 1.70 
Unmarried partner  2 5.90 1 4.00 3 5.10 
Alcohol (Pearson chi2(1) = 0.3590, P = 
0.549)       
Yes 15 44.10 13 52.00 28 47.50 
No 19 55.90 12 48.00 31 52.50 
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Characteristic 
Aneurysmal Nonaneurysmal Total 
n % n % N % 
Smoker (Pearson chi2(1) = 0.5889 P = 
0.443)       
Yes 8 24.20 4 16.00 12 20.70 
No 25 75.80 21 84.00 46 79.30 
Family history of SAH (Fisher’s=0.034)       
Yes 7 21.20 0 0.00 7 12.70 
No 26 78.80 22 100.00 48 87.30 
Person completing survey (Fisher’s=0.249)       
Self 28 80.00 24 96.00 52 86.70 
Help from family/friend 3 8.60 0 0.00 3 5.00 
Completed by family/friend 4 11.40 1 4.00 5 8.30 
Employed (Pearson (chi2(1) = 4.8615 P =0.027)      
Yes 29 85.30 15 60.00 44 74.60 
No 5 14.70 10 40.00 15 25.40 
Employed in same position post SAH 
(Fisher’s=0.033)      
Yes 21 63.60 13 52.00 34 58.60 
No 8 24.20 2 8.00 10 17.20 
Non applicable 4 12.10 10 40.00 14 24.10 
Insurance Refusal  (Fisher’s=1.000)       
Yes 2 5.90 1 4.20 3 5.20 
No 32 94.10 23 95.80 55 94.80 
Subject perceived QOL change (Pearson chi2(1) = 0.9221, 
P=0.337)     
Yes 18 54.50 10 41.70 28 49.10 
No 15 45.50 14 58.30 29 50.90 
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Characteristic 
Aneurysmal Nonaneurysmal Total 
n % n % N % 
Physical Symptoms since SAH (Pearson chi2(1) = 2.2445 P = 
0.134)     
Yes 23 71.90 12 52.20 35 63.60 
No 9 28.10 11 47.80 20 36.40 
Emotional symptoms since SAH (Pearson chi2(1)= 0.4329 
P=0.511)     
Yes 17 48.60 10 40.00 27 45.00 
No 18 51.40 15 60.00 33 55.00 
Participated in PT (Pearson chi2(1) = 6.6379 P = 0.010)     
Yes 23 65.70 8 32.00 31 51.70 
No 12 34.30 17 68.00 29 48.30 
Participated in OT (Pearson chi2(1) = 4.3073 P = 0.038)     
Yes 14 41.20 4 16.00 18 30.50 
No 20 58.80 21 84.00 41 69.50 
Participated in speech therapy 
(Fisher’s=0.223)       
Yes 6 18.20 1 4.50 7 12.70 
No 27 81.80 21 95.50 48 87.30 
Received psychiatric counseling (Fisher’s=1.000)      
Yes 5 15.20 3 12.00 8 13.80 
No 28 84.80 22 88.00 50 86.20 
Received other types of treatment (Pearson chi2(1) = 0.0476 P= .827)    
Yes 8 24.20 5 21.70 13 23.20 
No 25 75.80 18 78.30 43 76.80 
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Continuous variables linked to time or specific instrument scores are shown for subjects 
classified as aneurysmal versus nonaneurysmal in Table 5.  These groups did not differ 
significantly by age, time since hemorrhage, and time smoking or drinking alcohol, nor did they 
differ significantly in their PTSD, FSSQ, SS-QOL, and SF-12 scores. The only significant 
differences were their time participating in PT and OT, which confirms the findings in Table 1. 
In other words, aneurysmal patients are offered more PT/OT services, and when they both have 
services, the aneurysmal group participates longer in both physical and occupational therapy. 
Table 5  
Distribution of Continuous Variables by Hemorrhage Type 
Variable 
Aneurysmal  Nonaneurysmal 
p1a p2b 
Mean ± SD n Mean ± SD n 
Age 
55.7
1  
± 11.
3 
35 59.28 ± 10.7 25 0.22
3 
 
Time since SAH, months  
30.4
9  
± 11.
6 
35 27.84 ± 9.7 25 0.35
6 
0.43
5 
Time smoking, years 
8.03 ± 15.
4 
33 4.4  ± 11.1 25 0.32
3 
0.39
3 
Drinks per week 
2.3  ± 4.1 34 3.2  ± 4.3 25 0.39
9 
0.36
1 
Duration of PT, weeks 
15  ± 35.
6 
34 2.84  ± 5.6 25 0.09
7 
0.01
1 
Duration of OT, weeks  
7.91 ± 18.
9 
33 1.44  ± 5.0 25 0.10
1 
0.03
4 
Duration of speech therapy, 
weeks 
3.5  ± 10.
7 
32 0.09  ± 0.4 22 0.14
2 
0.18
1 
Duration of psych, weeks 
3.0  ± 10.
2 
32 1.08  ± 4.5 24 0.39
3 
0.57
9 
Duration of other TX, weeks 3.0  ± 10. 29 3.6  ± 11.7 20 0.85 0.74
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2 8 
PTSD Score 
1.83 ± 0.9 35 1.74  ± 0.9 24 0.69 0.36
9 
FSSQ Score 
4.33 ± 0.8 33 4.4  ± 0.8 24 0.75
8 
0.53
5 
Overall QOL - SS-QOL 
3.66 ± 0.9 34 3.97  ± 1.0 24 0.24
7 
0.11
1 
SF-12 PCS score 
43.0
7  
± 10.
1 
34 46.36 ± 9.9 21 0.24
2 
0.15
5 
SF-12 MCS score 
37.8
3  
± 9.5 34 37.29 ± 12.2 21 0.85
5 
0.74
2 
ap1 : significance determined by t-test 
bp2 : significance determined by Wilcoxon rank-sum (Mann-Whitney) test 
The SS-QOL subscale scores of aneurysmal and nonaneurysmal subjects are compared in 
Table 6. Of the 12 SS-QOL subscales that measure specific domains of health-related quality of 
life, two had significantly different scores between the groups. The aneurysmal population had 
worse scores in the mood and personality domains. The mood domain indicates interest in social 
interactions and overall view of one’s future. The personality domain indicates one’s general 
daily disposition or changes to personality since subarachnoid hemorrhage. Overall the two 
groups were homogenous in their SS-QOL scores, similar to the findings in Table 1. 
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Table 6 
Distribution of SS-QOL Subscale Scores by Group 
SS-QOL Subscale 
Aneurysmal  Nonaneurysmal 
p1a p2b 
mean ± SD n mean ± SD n 
Mobility  3.96 ± 1 34 3.99 ± 1.3 24 0.921 0.532 
Energy  3.25 ± 1.1 34 3.51 ± 1.4 24 0.43 0.174 
Upper Extremity  4.0 ± 1.2 34 4.21 ± 1 24 0.488 0.237 
Work/Productivity  3.97 ± 1.1 34 4.2 ± 2.5 24 0.641 0.890 
Mood  3.54 ± 1.1 34 4.06 ± 1.1 24 0.082 0.045 
Self-Care  4.22 ± 1 34 4.33 ± 1.0 24 0.656 0.184 
Social Roles 3.3 ± 1.3 34 3.79 ± 1.3 24 0.171 0.197 
Family Role  3.68 ± 1.2 35 4.06 ± 1.1 24 0.214 0.130 
Vision  4.14 ± 0.9 34 4.36 ± 0.8 24 0.335 0.163 
Language  3.85 ± 1.2 34 4.13 ± 0.9 24 0.35 0.620 
Thinking  3.01 ± 1.2 34 3.29 ± 1.2 24 0.404 0.383 
Personality  3.09 ± 1.2 34 3.69 ± 1.1 24 0.055 0.049 
ap1 : significance determined by t-test 
bp2 : significance determined by Wilcoxon rank-sum (Mann-Whitney) test 
The overall distributions (mean, standard deviation, range) for all continuous variables 
are shown in Table 7. These continuous variables include age, cigarette and alcohol use, and 
overall PTSD and FFSQ scores. These results demonstrate that the subarachnoid hemorrhage 
patients, as a group, had low levels of PTSD and high levels of social support.  
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Table 7 
Overall Distribution of All Continuous Variables 
Variable 
n Mean SD 
Range 
Min Max 
Age, years 60 57.20 11.09 25.00 85.00 
Cigarette use, years 58 6.47 13.74 0.00 49.00 
Drinks per week 59 2.66 4.17 0.00 15.00 
Duration of PT, weeks 59 9.85 27.78 0.00 200.00 
Duration of OT, weeks 58 5.12 14.87 0.00 100.00 
Duration of speech therapy, weeks 54 2.11 8.35 0.00 52.00 
Duration of Psych, weeks 56 2.18 8.23 0.00 52.00 
Duration of other TX, weeks  49 3.24 10.72 0.00 52.00 
PTSD Score  59 1.79 0.88 1.00 3.90 
FSSQ Social Support  57 4.36 0.81 1.63 5.00 
Subjective QoL  58 3.79 0.98 1.36 5.43 
SF-12 PCS score 55 44.33 10.07 21.80 59.14 
SF-12 MCS score 55 37.62 10.51 4.91 53.35 
SS-QOL Mobility 58 3.97 1.13 1.00 4.83 
SS-QOL Energy 58 3.35 1.25 1.00 4.75 
SS-QOL Upper Extremity 58 4.09 1.09 1.33 4.83 
SS-QOL Work Productivity  58 4.06 1.81 1.00 14.50 
SS-QOL Mood 58 3.76 1.13 1.17 4.83 
SS-QOL Self-Care 58 4.26 0.98 1.50 5.00 
SS-QOL Social Roles 58 3.50 1.33 1.00 5.00 
SS-QOL Family Roles 59 3.83 1.17 1.00 5.00 
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SS-QOL Vision 58 4.23 0.86 1.25 5.00 
SS-QOL Language 58 3.97 1.07 1.40 4.80 
SS-QOL Thinking 58 3.13 1.23 1.00 4.75 
SS-QOL Personality 58 3.34 1.17 1.00 4.75 
 
The reliabilities (Cronbach’s alphas) of instruments are presented in Table 8. All 
instruments in this study had excellent reliability. All alphas were at least as high if not higher 
than those of published studies. This study is the first to have tested the SS-QOL scale as a self-
administered scale, and it proved to have excellent reliability.  
Table 8 
Cronbach’s Alpha Reliabilities for Study Instruments  
Instrument Reliability from other 
studies 
Overall Study 
reliability 
(Cronbach’s α) 
Aneurysmal  
reliability 
(Cronbach’s α) 
NonAneurysmal 
reliability 
(Cronbach’s α) 
PTSD Not available 0.912 0.902 0.942 
FSSQ 0.81-0.92 0.924 0.926 0.924 
SF-12 0.76 (for aneurysm 
patients) 
0.894 0.877 0.914 
SS-QOL >0.73 for all domains 0.953 (0.979 for 
subscales) 
0.982 (0.957 
for subscales) 
0.976 (0.946 for 
subscales) 
 
Subjects’ responses to open-ended questions about physical and emotional symptoms 
experienced due to subarachnoid hemorrhage are shown and compared in Table 9. The subjects’ 
self-identified symptoms were grouped in like categories. The nonaneurysmal group had more 
physical symptom complaints, except for headaches, weakness and visual disturbance. The 
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aneurysmal group had more emotional symptoms. Interestingly, only the nonaneurysmal group 
had a fear of a second subarachnoid hemorrhage.  
Table 9 
Responses for Physical and Emotional Symptoms on Aneurysmal-Specific Questionnaire 
 
Type of Subarachnoid Hemorrhage 
Total 
Aneurysmal Nonaneurysmal 
n % n % n p 
Physical Symptoms       
Yes  23 71.9 12 52.2 35 (63%)         0.314 
No  9 28.1 11 47.8 20 (36.4%)  
Emotional Symptoms       
Yes 17 48.6 10 40.0 27(45%) 0.511 
No 18 51.4 15 60.0 33(55%)  
       
 
Table 10 
Detailed Responses for Physical and Emotional Symptoms on Aneurysmal-Specific 
Questionnaire 
 
Type of Subarachnoid Hemorrhage 
 
Aneurysmal Nonaneurysmal 
n % n % 
% 
Difference 
for NASAH 
% 
Tota
l 
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Type of Subarachnoid Hemorrhage 
 
Aneurysmal Nonaneurysmal 
n % n % 
% 
Difference 
for NASAH 
% 
Tota
l 
Physical Symptoms       
Headache 8 23 5 20 -3 22 
Fatigue 3 8 6 25 +17 15 
Numbness or decreased 
sensation 2 5 1 4 -1 4.5 
Trouble sleeping 2 5 4 16 +11 10 
Dizziness/Balance 2 5 5 20 +15 12 
Weakness 2 5 1 4 -1 4.5 
Visual disturbance 2 5 1 4 -1 4.5 
Incontinence 0 0 1 4 +4 4 
Emotional Symptoms       
Memory loss 8 23 3 12 -11 18 
Anxiety  11 32 4 16 -16 25 
Depression 7 20 2 8 -12 15 
Unclear Thinking 4 11 1 4 -7 8 
Fear of second SAH 0 0 4 16 +16 16 
 
Two separate questions from two separate instruments (the Aneurysmal-Specific and SS-
QOL Questionnaires) are compared in Table 11. This comparison is important since the main 
purpose of this study was to determine the effect of subarachnoid hemorrhage on health-related 
quality of life. The responses to the first question from the Aneurysmal-Specific Questionnaire 
(“My overall quality of life is the same as before my SAH”) were almost identical to responses 
 HRQOL in Subarachnoid Hemorrhage Patients 
62 
to the  question on the SS-QOL # 13 (“My overall QoL is …”). Among nonaneurysmal subjects, 
14 (58%) and 13 (59%) perceived their overall quality of life had not changed since the 
subarachnoid hemorrhage on the Aneurysmal-Specific and SS-QOL questionnaires, respectively. 
For aneurysmal subjects, 15 (45%) and 16 (49%) perceived no change on the Aneurysmal-
Specific and SS-QOL questionnaires, respectively. These results show consistency in subjects’ 
responses to very similar questions. The two groups were further tested by collapsing quality of 
life overall to 1=a lot worse than before to a little worse than before (1st 3 categories) and 2=the 
same as before my hemorrhage. The findings show both questions have similar responses. . 
Subjects that stated No to “My QoL has been affected by my SAH” are more likely to say the 
“Overall QoL” is the same as before.  Fisher's exact= 0.000. 
Table 11 
Perceived Effect of SAH on Quality of Life (QoL) Measured by Aneurysmal-Specific and SS-
QOL Questionnaires  
Question 
Type of Subarachnoid Hemorrhage 
Total 
Aneurysmal 
Nonaneurysma
l 
n % n % N % 
My QoL has been affected by my SAH 
(Aneurysmal-Specific Questionnaire)       
Yes 18 54 10 41 28 47.5 
No  15 45 14 58 29 51.5 
My overall QoL is: (SS-QOL)       
A lot worse than before my SAH 4 11 2 9 6 10 
A little worse than before my SAH 5 14 3 13 8 13.5 
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Question 
Type of Subarachnoid Hemorrhage 
Total 
Aneurysmal 
Nonaneurysma
l 
n % n % N % 
Somewhat worse than before my SAH 10 28 4 18 14 23 
The same as before my SAH 16 49 13 59 29 54 
 
Specific Aim 1: To describe the physical, psychological, social, and vocational impact of 
nonaneurysmal and aneurysmal subarachnoid hemorrhage on patients at 1 to 3 years post-
hemorrhage. 
The two groups did not differ significantly in mobility, energy, upper extremity, self-care, 
vision, and physical functioning between groups (Table 12). However, the two groups differed 
significantly in mood and personality as previously demonstrated (Table 6), with the aneurysmal 
group having more dysfunction (Table 13). On the other hand, the two groups did not differ in 
their overall SF-12 mental health component score (Table 13) nor in amount of social support 
(Table 11). Each group scored high on the Duke FSSQ (Table 14), and did differ significantly in 
terms of vocational impact of the subarachnoid hemorrhage (Fisher’s exact = 0.033) (Table 15).    
It appears that the nonaneurysmal subjects are less likely to be employed in the same position 
then aneurysmal subjects after the subarachnoid hemorrhage. However, the nonaneurysmal 
subjects they were less likely to be employed prior to subarachnoid hemorrhage (p=0.027). 
Table 12 
Physical Impact of Subarachnoid Hemorrhage by Hemorrhage Type 
 Aneurysmal Nonaneurysmal 
p1a p2b 
SS-QOL Subscale Mean ± SD n Mean ± SD n 
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Mobility  3.96 ± 1 34 3.99 ± 1.3 24 0.921 0.532 
Energy  3.25 ± 1.1 34 3.51 ± 1.4 24 0.43 0.174 
Upper Extremity  4 ± 1.2 34 4.21 ± 1 24 0.488 0.237 
Self-Care  4.22 ± 1 34 4.33 ± 1 24 0.656 0.184 
Vision  4.14 ± 0.9 34 4.36 ± 0.8 24 0.335 0.163 
SF-12 Physical Component Score (PCS)        
 
43.07 ± 10.
1 
34 46.36 ± 9.9 21 0.242 0.155 
ap1 : significance determined by t-test 
bp2 : significance determined by Wilcoxon rank-sum (Mann-Whitney) test 
Table 13 
Psychological Impact of Subarachnoid Hemorrhage by Hemorrhage Type 
 Aneurysmal Nonaneurysmal 
p1a p2b 
SS-QOL Subscale Mean ± SD n Mean ± SD n 
Mood  3.54 ± 1.1 34 4.06 ± 1.1 24 0.082 0.045 
Thinking  3.01 ± 1.2 34 3.29 ± 1.2 24 0.404 0.383 
Personality  3.09 ± 1.2 34 3.69 ± 1.1 24 0.055 0.049 
SF-12 Mental Component Score        
 37.83 ± 9.5 34 37.29 ± 12.2 21 0.855 0.742 
ap1 : significance determined by t-test due  
bp2 : significance determined by Wilcoxon rank-sum (Mann-Whitney) test. This was used as the 
histogram distribution was not normal, thus the Mann-Whitney test was used and the results are 
now the reference results for this table. 
Table 14 
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Social Impact of Subarachnoid Hemorrhage by Hemorrhage Type 
 Aneurysmal Nonaneurysmal 
p1a p2b 
SS-QOL Subscale Mean ± SD n Mean ± SD n 
Social Roles  3.3 ± 1.3 34 3.79 ± 1.3 24 0.171 0.197
Family Role  3.68 ± 1.2 35 4.06 ± 1.1 24 0.214 0.130
FSSQ Score  4.33 ± 0.8 33 4.4 ± 0.8 24 0.758 0.535
ap1 : significance determined by t-test 
bp2 : significance determined by Wilcoxon rank-sum (Mann-Whitney) test  
Table 15 
Vocational Impact of Subarachnoid Hemorrhage by Subarachnoid Hemorrhage Type 
 
Aneurysmal Nonaneurysmal Total 
n % n % N % 
Employed in the same position post SAH      
Yes 21 63.60 13 52.00 34 58.60 
No 8 24.20 2 8.00 10 17.20 
Non applicable 4 12.10 10 40.00 14 24.10 
Fisher’s=0.033 
 
Specific Aim 2: To examine differences in HRQOL between patients with NASAH and 
ASAH after controlling for severity of hemorrhage, age, and time since hemorrhage  
The two groups did not differ significantly in SF-12 physical component scores (Table 
16-18), even though the PCS score of the nonaneurysmal group was 3.30 units higher than that 
of the aneurysmal group. The relationship between PCS and age was not linear, especially 
skewed far to the left. Therefore, age was divided into categories, creating the need to treat age 
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as a categorical (rather than continuous) variable in regression analysis. The relationship between 
PCS and time was linear. However, the relationship between PCS and type of hemorrhage was 
not significant after adding age, time and Fisher score to the regression model (Table 19).  
The adjusted and unadjusted associations among variables are shown in Table 20.  The 
coefficients for type of hemorrhage in the unadjusted model were developed from the model 
MCS=type of hemorrhage.  The coefficients in the adjusted model for type of hemorrhage came 
from the model MCS=type of hemorrhage + Fisher score + age + time since hemorrhage. 
Although the difference between MCS scores of the two groups was still not significant, 
including the Fisher score, age, and time increased this difference.  The MCS score of the 
nonaneurysmal group was 2.03 units lower than that of the aneurysmal group (p=0.565). 
The overall average SS-QOL scores for aneurysmal and nonaneurysmal subjects were 
3.66 and 3.97, respectively.  The coefficients for type of hemorrhage in the unadjusted model 
came from the model SS-QOL overall=type of hemorrhage (Table 21).  The coefficients in the 
adjusted model for type of hemorrhage came from the model SS-QOL overall=type of 
hemorrhage + Fisher score + age quintile + time since hemorrhage. In both the unadjusted and 
adjusted models, SS-QOL did not differ significantly by type of hemorrhage.  The unadjusted 
model shows that overall SS-QOL was 0.53 units greater for the >1mm thick group than for the 
intraparenchymal group (p=.037). This significant association disappeared when other factors 
were adjusted for.  The unadjusted model shows a significant difference between the 1st and 4th 
age quintiles.  The overall SS-QOL score of the 4th quintile was 0.70 units greater than that of the 
1st quintile.  Similarly, the overall SS-QOL scores of the 1st and 5th quintiles were associated, 
with SS-QOL score for the 5th quintile 0.89 units higher than for the 1st quintile.  This association 
was not as strong in the adjusted model, where only the 5th quintile groups still showed a 
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significant association.  Overall SS-QOL score was not significantly associated with time post 
hemorrhage in either model. 
Table 16 
SF-12 PCS (Physical Component Score) by Type of Hemorrhage  
Type of Hemorrhage 
n Mean SD 
Range 
Max Min 
Aneurysmal  34 43.06559 10.13899 59.14 22.57 
Nonaneurysmal  21 46.36476 9.86555 57.41 21.8 
Total 55 44.32527 10.07403 59.14 21.8 
 
Table 17 
Linear Regression for PCS by Type of Hemorrhage (N=55; Outcome variable =PCS) 
Type of Hemorrhage 
Coefficient SE P (t-test) 
95% Confidence 
Interval 
Lower Upper 
Aneurysmal a 0     
Nonaneurysmal  3.299 2.786 0.242 -2.288  8.886 
a Baseline category 
Table 18 
Linear Regression PCS by Type of Hemorrhage (N=55; Outcome variable =PCS2) 
Type of Hemorrhage 
Coefficien
t SE P (t-test) 
95% Confidence Interval 
Lower Upper 
Aneurysmal a 0     
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Nonaneurysmal  287.965 229.901 0.216 -173.158 749.088 
a Baseline category 
 
Table 19 
PCS Score by Hemorrhage Type after Adjusting for Age, Hemorrhage Type, and Time since 
Hemorrhage 
 Outcome Variable PCS, n=55 Transformed Outcome Variable PCS2, n=55 
B? 
β? SE 95% CI p
a B? β? SE 95% CI pa 
Type of 
hemorrhage  
        
Aneurysmal a 0     0    
Nonaneurysmal 2.37
2 
3.111 -3.891 to 
8.635 
0.450 218.00  258.1
0 
-301.53 
to 737.53
0.40
3 
Fisher Score    0.561    0.60
0 
Intraparenchymal 
a 
0    0    
<1mm thick  2.76
3      
6.836 -10.998 
to 16.524 
0.688 198.304  567.0
9 
-943.20 
to 
1339.81 
0.72
8   
>1mm thick 3.53
6      
3.331   -3.169 to 
10.241 
0.294   278.687  276.3
3 
-277.54 
to 834.91
0.31
8   
Age Quintile, 
years 
   0.915    0.96
1 
1 
a  
<49.2  0        
2 49.2 to <56 1.55
4      
4.807 0.748 to -
11.229 
0.748 116.857  3.987
2 
-685.72 
to 919.43
0.77
1   
 HRQOL in Subarachnoid Hemorrhage Patients 
69 
3    56 to 60.6 0.16
6      
4.419 -8.730 to 
9.062 
0.970 -21.503   366.6
1 
-759.45 
to 716.44
0.95
3   
4   60.6 to <65.5 1.16
4      
4.912 -8.723 to 
11.051 
0.814 49.158   407.4
5 
-770.99 
to 869.30
0.90
4   
5  >65.5 3.97
0      
4.516   -5.121 to 
13.061 
0.384   241.206  374.6
5 
-512.92 
to 995.33
0.52
3   
Time post 
hemorrhage, 
months 
0.15
1      
0.146 -0.143 to 
0.445 
0.307 12.616   12.12
4      
-11.789 
to 37.021
0.30
4    
a Baseline category; PCS2  is transformed  because PCS was not normally distributed. 
 
 
Table 20 
Transformed SF-12 Mental Component Score (MCS) Scores by Hemorrhage Type after 
Adjusting for Age, Type of Hemorrhage, and Time since Hemorrhage 
 Unadjusted Adjusted 
B? β? SE 95% CI p a B? β? SE 95% CI p a 
Type of hemorrhage         
Aneurysmal b 0    0    
Nonaneurysmal -0.54 2.94 -6.44 to 
5.36 
0.947 -2.03 2.76 -7.58 to 
3.52 
0.565 
Fisher Score         
Intraparenchymal b 0    0    
<1mm thick  -7.25 6.26 -19.81 
to 5.31 
0.307 -6.23 5.82 -17.92 
to 5.47 
0.338 
>1mm thick 3.69 2.93 -2.18 to 
9.56 
0.108 2.19 2.87 -3.59 to 
7.96 
0.288 
Age 0.44 0.11 0.21 to 
0.67 
<0.00
1 
0.43 0.12 0.19 to 
0.67 
<0.001 
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 Unadjusted Adjusted 
B? β? SE 95% CI p a B? β? SE 95% CI p a 
Time post 
hemorrhage, months 
-0.05 0.13 -0.31 to 
0.21 
0.584 -0.03 0.12 -0.27 to 
0.21 
0.725 
a p is from transformed data.   
b Reference group 
 
 
 
 
Table 21 
Transformed  Stroke Scale Quality of Life (SS-QOL) Score by Hemorrhage Type after Adjusting 
for Age, Type of Hemorrhage, and Time since Hemorrhage 
 Unadjusted Adjusted 
 B? β? SE 95% CI pa B? β? SE 95% CI pa 
Type of hemorrhage         
     Aneurysmal b 0    0    
     Nonaneurysmal 0.30 0.26 -0.22 to 
0.82 
0.167 0.20 0.26 -0.32 to 
0.72 
0.38
1 
Fisher Score         
     Intraparenchymalb 0    0    
     <1mm thick  -0.48 0.50 -1.49 to 
0.52 
0.519 -0.61 0.54 -1.70 to 
0.48 
0.34
5 
     >1mm thick 0.53 0.26 0.01 to 0.037 0.46 0.28 -0.11 to 0.09
 HRQOL in Subarachnoid Hemorrhage Patients 
71 
1.06 1.02 9 
Age Quintile         
     1b 0    0    
     2 -0.006 0.395 -0.80 to 
0.79 
0.725 0.064 0.43 -0.79 to 
0.92 
0.68
9 
     3 -0.03 0.37 -0.77 to 
0.71 
0.990 -0.27 0.38 -0.99 to 
0.54 
0.60
9 
     4 0.70 0.38 -0.08 to 
1.47 
0.062 0.44 0.41 -0.38 to 
1.27 
0.27
1 
     5 0.89 0.38 0.14 to 
1.65 
0.014 0.79 0.38 0.03 to 
1.54 
0.03
1 
Time post hemorrhage, 
months 
0.000 0.012 -0.02 to 
0.02 
0.974 0.01 0.01 -0.01 to 
0.04 
0.23
0 
a p was determined using transformed data.   
b Reference group 
Specific Aim 3: To examine the effects of employment status, PTSD, and social support (by 
adjusting for each variable) on HRQOL for patients with NASAH and ASAH and to 
determine if the adjustment accounts for any HRQoL differences between NASAH and 
ASAH patients.  
The SF-12 PCS score of the unemployed group was 5.55 units smaller than that of the employed 
group (reference group), but this difference was not significant (p=0.093) (Table 22).  The PCS 
score decreased significantly (p=0.013), by 4.19 units for every 1 unit increase in the PTSD score 
(Table 23). The relationship between PCS and social support was linear except for a small 
skewedness for the far left side. Thus, new social support categories (terciles) were created.  The 
2nd tercile group had a PCS score 1.32 units greater than that of the 1st tercile group (reference 
group), but this difference was not significant (p=0.665) (Table 24). Similarly, the PCS score of 
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the 3rd tercile group was 2.98 units greater than that of the 1st tercile group (reference), but this 
difference was not significant (p=0.409) (Table 24). 
The association of the SF-12 PCS score with type of hemorrhage did not become 
significant when employment, PTSD score, and social support were added to model (Table 25). 
These extra variables did not explain more of the variance in PCS score between the aneurysmal 
and nonaneurysmal groups.  
The SF-12 MCS score of the unemployed group was 3.15 units greater than that of the 
employed (reference) group, but this difference was not significant (p=0.373) (Table 26).  MCS 
scores decreased significantly (p<0.001), by 7.12 units for every 1 unit increase in PTSD score 
(Table 26). 
The MCS score for the 2nd tercile group was 4.85 units larger than that of 1st tercile 
(reference group), but this difference was not significant (p=0.107) (Table 28). However, the 
MCS score of the 3rd tercile group was significantly larger (p=0.009), by 7.71 units than that of 
the 1st tercile (reference group) (Table 28).   
The association of the SF-12 MCS score with type of hemorrhage did not become 
significant when employment score, PTSD score, and social support were added to the model 
(Table 29).  These extra variables did not explain more of the variance in the MCS score between 
the aneurysmal and nonaneurysmal groups. 
Overall SS-QOL score of the unemployed group was 0.35 unit smaller than that of the 
employed (reference) group, but this difference was not significant (p=0.382) (Table 30).  
Overall SS-QOL score decreased significantly (p<0.001), by 0.82 unit for every 1 unit increase 
in the PTSD score (Table 31).  Overall SS-QOL score increased significantly (p=0.001), by 0.53 
units for every 1 unit increase in the FSSQ score (Table 32). 
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The association of the overall SS-QOL score with type of hemorrhage did not become 
significant when employment, PTSD score, and FFSQ score were added to the model (Table 33).  
These extra variables did not explain more of the variance in overall SS-QOL score between the 
aneurysmal and nonaneurysmal groups. 
The results from Specific Aim 3 show that patients with higher PTSD scores (more 
PTSD) had lower scores on the SF-12 PCS and MCS as well as overall SS-QOL, indicating 
worse health-related quality of life. Patients with more social support (FSSQ) had higher overall 
SS-QOL scores, increasing their HRQoL.  Adjusting for the effects of employment status, PTSD, 
and social support did not account for any differences in HRQoL between patients with NASAH 
and ASAH. 
Table 22 
Relationship between PCS Score and Employment Status, N=55 
 B? β? SE 95% CI pa 
Education     
Yes (reference) 0    
No -5.55 3.14 -11.84 to 0.74 0.093 
a p was determined from transformed data 
Table 23 
Relationship between PCS and PTSD Scores, N=54 
 B? β? SE 95% CI pa 
PTSD Score     
Per unit -4.19 1.51 -7.21 to -1.17 0.013 
a p was determined from transformed data 
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Table 24 
Relationship between PCS and Social Support Scores, N=53 
 B? β? SE 95% CI pa 
FSSQ score – social support tercile     
1st tercile <4.125 (reference) 0    
2nd tercile >4.125 to 4.875 1.32 3.46 -5.62 to 8.27 0.665 
3rd tercile >4.875 2.98 3.46 -3.97 to 9.93 0.409 
a p was determined from transformed data  
Table 25 
PCS Score by Hemorrhage Type after Adjusting for Employment Status, PTSD and Social 
Support, N=53 
 B? β? SE 95% CI pa 
Type of hemorrhage     
Aneurysmal (reference) 0    
Nonaneurysmal  3.62 2.81 -2.02 to 9.27 0.196 
Employed     
Yes (reference)     
No -6.50 3.28 -13.09 to 0.096 0.061 
PTSD Score     
Per unit -3.62 1.58 -6.79  to -0.44 0.043 
FSSQ score – social support tercile     
1st tercile <4.125 (reference) 0    
2nd tercile >4.125 to 4.875 -0.49 3.25 -7.02 to 6.04 0.950 
3rd tercile >4.875 1.81 3.34 -4.91 to 8.54 0.591 
 HRQOL in Subarachnoid Hemorrhage Patients 
75 
a p was determined from transformed data  
Table 26 
Relationship between MCS Score and Employment Status, N=55 
 B? β? SE 95% CI pa 
Employed     
Yes (reference) 0    
No 3.15 3.34 -3.55 to 9.84 0.373 
a p was determined from transformed data 
Table 27 
Relationship between MCS and PTSD Scores, N=54 
 B? β? SE 95% CI pa 
PTSD Score     
Per unit -7.12 1.19 -9.51 to -4.74 <0.001 
a p was determined from transformed data 
Table 28 
Relationship between MCS and Social Support Scores after Adjusting for Social Support, N=53 
 B? β? SE 95% CI pa 
FSSQ score – social support 
terciles 
    
1st tercile <4.125 (reference) 0    
2nd tercile >4.125 to 4.875 4.85 3.08 -1.33 to 11.03 0.107 
3rd tercile >4.875 7.71 3.08 1.53 to 13.89 0.009 
a p was determined from transformed data  
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Table 29 
PCS Score by Hemorrhage Type after Adjusting for Employment Status, PTSD Score, and Social 
Support, N=53  
 B? β? SE 95% CI pa 
Type of hemorrhage     
Aneurysmal (reference) 0    
Nonaneurysmal -0.57 2.16 -4.91 to 3.78 0.910 
Employed     
Yes (reference)     
No 3.76 2.52 -1.31 to 8.84 0.178 
PTSD Score     
Per unit -6.71 1.21 -9.16 to -4.27 <0.001 
FSSQ score – social support terciles     
1st tercile <4.125 (reference) 0    
2nd tercile >4.125 to 4.875 3.30 2.50 -1.72 to 8.32 0.172 
3rd tercile >4.875 3.78 2.57 -1.39 to 8.95 0.089 
a p was determined from transformed data 
Table 30 
Relationship between Overall SS-QOL Score and Employment Status, N=58 
 B? β? SE 95% CI pa 
Employed     
Yes (reference) 0    
No -0.35 0.29 -0.93 to 0.24 0.382 
a p was determined from transformed data  
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Table 31 
Relationship between Overall SS-QOL Score and PTSD, 
 B? β? SE 95% CI pa 
PTSD Score     
Per unit -0.82 0.10 -1.02 to -0.62 <0.001 
a p was determined from transformed data 
 
Table 32 
Relationship between SS-QOL and FFSQ Scores, N=57 
 B? β? SE 95% CI pa 
FSSQ score – social support      
Per unit 0.53 0.15 0.24 to 0.83 0.001 
a p was determined from transformed data 
Table 33 
Overall QOL Score by Hemorrhage Type after Adjusting for Employment Status, PTSD Score, 
and FSSQ Score, N=57 
 B? β? SE 95% CI pa 
Type of hemorrhage     
Aneurysmal (reference) 0    
Nonaneurysmal 0.26 1.84 -0.11 to 0.63 0.122 
Employed     
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Yes (reference)     
No -0.18 0.21 -0.60 to 0.24 0.597 
PTSD Score     
Per unit -0.72 0.11 -0.93 to -0.51 <0.001 
FSSQ score – social support      
Per unit 0.23 0.11 0.003 to 0.46 0.058 
a p was determined from transformed data 
Specific Aim 4: To describe management strategies used by patients with nonaneurysmal 
and aneurysmal subarachnoid hemorrhage that helped improve their HRQoL   
Few study participants responded to questions about received or potential treatments. 
Only 11 subjects responded to the question on what they found helpful during their recovery 
process, and only 14 described other treatments they perceived could be helpful if they had been 
offered. The results in Table 34 demonstrate that patients used alternative therapies such as 
acupuncture or massage therapy. Subjects also found it helpful to have more information from 
both the neurosurgery team and rehabilitation facility during hospitalization or more frequent 
contact once discharged. They also cited home care requirements for additional nursing services 
or adaptive equipment.  Finally, once the subjects were at home and processing the ramifications 
of a subarachnoid hemorrhage, they either benefited from or might benefit from social workers 
or support groups. 
Table 34 
Other Treatments Found to Helpful after Subarachnoid Hemorrhage  
Treatment 
Type of Subarachnoid 
Hemorrhage Total 
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Aneurysmal Nonaneurysmal 
n % n % N % 
Acupuncture 1 2 0 0 1 1 
Anxiety medication 0 0 1 4 1 1 
Remained in contact with rehab 1 2 0 0 1 1 
Earlier follow-up with neurosurgeon 0 0 1 4 1 1 
Home adaptive equipment 0 0 1 4 1 1 
Aide at home 1 2 0 0 1 1 
Massage therapy 1 2 0 0 1 1 
Neuro-ophthalmology 1 2 0 0 1 1 
Support group 1 2 0 0 1 1 
Visiting nurse 1 2 1 4 2 3 
 
Table 35 
Treatments Subjects Perceived Could Have Been Helpful Had They Been Offered  
Treatment 
Type of Subarachnoid Hemorrhage 
Total 
Aneurysmal 
Nonaneurysma
l 
n % n % N % 
Additional PT 2 .05 1 .04 3 .05 
More information about diagnosis/prognosis 
while hospitalized  3 .08 1 .04 4 .06 
Social services 1 .02 0 0 1 .01 
Speech and language therapy 1 .02 0 0 1 .01 
Psychiatric counseling 1 .02 1 .04 2 .01 
Insurance to pay for acupuncture 1 .02 0 0 1 .01 
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Treatment 
Type of Subarachnoid Hemorrhage 
Total 
Aneurysmal 
Nonaneurysma
l 
n % n % N % 
More follow-up with neurosurgeon  0 0 1 .04 1 .01 
Support group 1 .02 0 0 1 .01 
 
Summary 
The results of this chapter and study were generated by analysis of quantitative data 
collected from six instruments. These results show that patients with aneurysmal and 
nonaneurysmal subarachnoid hemorrhage had more similarities than differences. This outcome is 
consistent with the underpinning hypothesis for this study, i.e., that the health-related quality of 
life of these groups would not differ significantly before and after controlling for severity of 
hemorrhage, age, and time since hemorrhage. 
The nonaneurysmal group had more subjective physical symptom complaints, and the 
aneurysmal group had more emotional symptoms. However, the nonaneurysmal group had a 
lower SF-12 mental component score (MCS), by 2.03 units, than the aneurysmal group.  
Only the nonaneurysmal group feared having a second subarachnoid hemorrhage.  The two 
groups differed significantly in their employment status; only 52% of nonaneurysmal patients 
were employed post hemorrhage in the same position as before their hemorrhage versus 63% of 
aneurysmal patients.  
Both groups had low levels of PTSD, and these levels did not differ significantly between 
groups. However, PTSD and social support were shown by regression analysis to impact 
HRQoL. Subjects with higher PTSD scores (more PTSD symptoms) had lower scores on both 
the SF-12 and overall SS-QOL scores, indicating worse health-related quality of life. Subjects 
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with more perceived social support had higher overall SS-QOL scores, and greater HRQoL.  
Lastly, the subjects reported wanting more information about their diagnosis/plan of care during 
all phases of acute inpatient hospitalization, during rehabilitation, and upon discharge.  
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Chapter V 
Discussion 
 
Introduction 
This chapter discusses the similarities and differences found in patients 12 to 30 months 
following an aneurysmal subarachnoid hemorrhage (ASAH) versus a nonaneurysmal 
subarachnoid hemorrhage (NASAH). The impacts of NASAH and ASAH on health-related 
quality of life (HRQOL), symptomatology and employment status are discussed in detail.  
Additionally, the effects of post traumatic stress disorder (PTSD) and social support on HRQOL 
are presented. Finally, the study limitations and implications for practice, policy and future 
research are discussed. 
Of the 34 demographic and clinical characteristics examined in this study, only 6 were 
found to differ significantly between the ASAH and NASAH groups (Fisher grade, family 
history of SAH, employment before SAH, employment after SAH, and participation in physical 
therapy (PT) and occupational therapy (OT). ASAH patients had significantly greater Fisher 
grade scores than NASAH patients. This difference was expected given that intraparenchymal 
and intraventricular blood can occur as part of aneurysmal rupture, and such a difference is seen 
consistently throughout the literature (Beseoglu et al., 2009; Hutter & Gilsbach, 1995; Hutter et 
al., 2001; 2001; Katati et al., 2007; Zebian, 2011). Due to the large size of these hemorrhages, 
aneurysmal patients generally have more physical disability and require physical and 
occupational therapy, explaining the significant difference in PT and OT participation in these 
groups. Participation in physical and occupational therapy has not been specifically researched in 
any other studies. Only 52% of nonaneurysmal patients remained employed in the same position 
post subarachnoid hemorrhage versus 63% of aneurysmal patients. These findings are 
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counterintuitive as the ASAH patients generally have more physical disability and thus would be 
considered less likely to return to work. However, inability to work post NASAH has been 
frequently demonstrated in the literature (Beseoglu et al., 2009; Brilstra et al., 1997; Marquardt 
et al., 2000).  
HRQOL 
This is the second study comparing HRQOL outcomes between aneurysmal and 
nonaneurysmal subarachnoid hemorrhage patients. The first study, by Hutter and Gilsbach 
(1995), focused on cognitive deficits 1–5 years after subarachnoid hemorrhage. Hutter and 
Gilsbach concluded that no significant differences in cognitive deficits could be found between 
the two groups. They also measured HRQOL using the Freiburg Personality Inventory (FPI-R) 
by self-report and proxy ratings. Substantial impairments in HRQOL were reported by 50% of 
patients and their life companions self by self-rating. That self-reported finding is comparable to 
our study, as 41–55% of both groups reported their quality of life had been adversely affected by 
the subarachnoid hemorrhage. Hutter and Gilsbach recommended that patients and their families 
should be better informed about their SAH in order to make better decisions in the future about 
the need for extended services or the vocational impact of the SAH. Our participants reported 
wanting more information about their diagnosis/plan of care during all phases of acute inpatient 
hospitalization, during rehabilitation, and upon discharge.  
To our knowledge, our study is only the second study to directly compare and contrast 
long-term HRQOL in patients who had ASAH and NASAH. Other studies have examined 
HRQOL in samples of either ASAH or NASAH patients.  
The NASAH studies have contradictory results. For example, it has been suggested that NASAH 
patients have less dysfunction and that this type of hemorrhage is benign (Brilstra et al 1997).  
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The Bristla study was one of the first studies to specifically look at NASAH, and it concluded 
that NASAH was a “benign” condition. In contrast Marquardt et al, (2000) found that NASAH 
patients have considerable long-term psychosocial consequences post hemorrhage.  For example, 
the majority of patients had residual complaints of headache, irritability, forgetfulness, 
depression, weariness, and reduced endurance at follow up. These findings are consistent with 
our study, which found residual complaints of headache, fatigue, memory loss and anxiety 
among our sample.  In addition, the Marquardt et al., study also demonstrated similar 
employment issues as the current study.  Of 17 patients who had been working before the 
hemorrhage, less than half returned to their previous occupation, 9 retired from work, and 1 
became unemployed.  
In contrast to the NASAH studies that focused on the consequences of a subarachnoid 
hemorrhage, many of the ASAH studies have tried to predict what factors predict long term 
HRQOL. Most recently, a meta-analysis by Noble and Schenk (2010) found that the traditional 
predicator variables of exam on admission and size of bleed do not explain impairment in 
HRQOL. Therefore, the cause of most HRQOL impairment after SAH remains unknown. Noble 
and Schenk (2010) suggested that only physical disability affected HRQOL (large effect size of 
0.54). Age had a small-to-moderate effect size on HRQOL (effect size = 0.20). The situation is 
even worse for the impact to the mental health component of HRQOL, an area often significantly 
affected in SAH patients. Here, 90% of the variance remains unexplained by traditional 
predictors (Noble & Schenk, 2010). Using the Stroke Scale Quality of Life SSQOL instrument, 
we identified that only the aneurysmal population had worse scores in the mood and personality 
domains. The mood domain reflects interest in social interactions and overall view of one’s 
future. The personality domain indicates one’s general daily disposition or changes to personality 
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since subarachnoid hemorrhage. We recommend using the SSQOL tool to help narrow the 
variance found in the mental health component of HRQOL. Our study also confirms that mood 
disturbances and maladadaptive coping skills after SAH have been found in other studies ( 
Visser-Meily et al., 2009).  
Employment  
Previous studies have demonstrated that returning to work is a major challenge for 
individuals who survive a SAH (Beseoglu et al., 2009; Brilstra et al., 1997; Hop et al., 2001; 
Hutter & Gilsbach (1995); Marquardt et al., 2000; Wermer et al. (2007).  In this study, NASAH 
subjects were less likely then ASAH subjects to be employed prior to subarachnoid hemorrhage. 
We are unaware of any other studies that have looked at employment prior to subarachnoid 
hemorrhage. One possible explanation for this finding is that the NASAH group may have had 
more retirees in the cohort as the NASAH group was approximately 2 years older. The NASAH 
median age was 59.28 versus 55.7 for the ASAH group. Of those who were employed prior to 
their hemorrhage, fewer NASAH patients remained employed in the same position post-
subarachnoid hemorrhage compared with ASAH patients. Prior studies have not directly 
compared the difference in employment status between both hemorrhage groups. However, 
employment status has been studied in both NASAH and ASAH samples. The nonaneurysmal 
studies suggested that NASAH patients have difficulty returning to a similar position or to work 
at all (Beseoglu et al., 2009; Brilstra et al., 1997; Marquardt et al., 2000). In fact, the 1997 
Brilstra et al. study had only two significant findings, and one was inability to work. Brilstra et 
al. found that of the 25 patients, six (24%) reported more dysfunction in the category of work 
than the general population. In the 2009 study by Beseoglu et al., only 8 of 19 (42%) NASAH 
subjects were able to return to their jobs. In the one combined study of both groups by Hutter & 
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Gilsbach (1995), participants reported employment-related difficulties (n = 5, 8%), lost their job 
or were demoted (n = 5, 8%), or had to retire (n = 9, 15%). Only two ASAH studies looked at the 
effects of employment. Hop et al. (2001) found that 94% of patients were unable to return to the 
same work position, while Wermer et al. (2007) found that 26% of ASAH patients stopped 
working, and 24% worked shorter hours. This compares with our study which found the two 
groups differed significantly in their employment status; only 52% of nonaneurysmal patients 
were employed post hemorrhage in the same position as before their hemorrhage versus 63% of 
aneurysmal patients. The literature tends to suggest that the ASAH patients may have greater 
employment problems post hemorrhage compared to the NASAH patients. However, our 
findings contrast with this notion.  
The variance between ASAH and NASAH changes when we compare the percent in 
same work position omitting, rather than including, those not employed prior to hemorrhage. 
There were a total of 21 ASAH and 13 NASAH working in the same position post hemorrhage. 
There were 29 ASAH and 15 NASAH employed prior to the hemorrhage which means 
comparing employed before and after hemorrhage 72% ASAH remained employed and 86% 
NASAH remained employed. 
Our study confirms previous findings that there is a significant and similar impact on 
employment for both hemorrhage groups.  It is not clear why NASAH patients in this study had 
more difficulty returning to their same position. One can hypothesize that perhaps baseline 
differences in education may account for different types of job responsibilities and therefore 
account for these differences between the two groups. The nonaneursymal group tended to have 
more bachelor’s or graduate level degrees as compared to the aneurysmal group (58% versus 
37%) and thus may have held positions that required higher levels of concentration or advanced 
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skills. These findings may also be related to our small sample size and the possibility that study 
respondents did not represent the actual population of SAH patients. 
Long-term Symptoms. 
To better evaluate the HRQOL in subarachnoid hemorrhage patients, we examined both 
physical and psychological symptoms. Our study found that the nonaneurysmal group had more 
physical symptom, while the aneurysmal group had more emotional symptoms. Of the 12 SS-
QOL subscales that measure specific domains of HRQOL, two had significantly different scores 
between the groups: the aneurysmal population had worse scores on the mood and personality 
domains.   
These findings differ slightly from other nonaneurysmal studies. The NASAH patient 
population has specifically been examined in five long term follow-up studies (Beseoglu et al., 
2009; Brilstra et al., 1997; Greebe & Rinkel, 2007; Gupta et al., 2009; Marquardt et al., 2000). 
All of these studies found this group to suffer from symptoms such as headache, irritability, 
forgetfulness, depression, weariness, and reduced endurance. Our study confirmed the finding of 
headaches and reduced endurance, but the remaining symptoms found in the other studies were 
more consistent with the aneurysmal group symptoms. One recent study of aneurysmal patients 
that also used the SSQOL (Visser-Meily et al., 2009) found similar findings to our study. They 
found higher scores in the physical domain and lower scores in the emotional and social 
domains. All psychological symptoms and personality characteristics were strongly related to the 
total HRQOL score. Similarly, our study found lower scores in the mood and personality 
domains for the aneurysmal population in both the unadjusted and adjusted models. However, 
the SS-QOL overall score did not differ significantly by type of hemorrhage. The unadjusted 
model shows that overall SSQOL score was 0.53 units greater for the >1mm-thick group than for 
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the intraparenchymal group. This significant association disappeared when other factors such as 
age and time since hemorrhage were adjusted for. The other study that specifically looked at 
NASAH with intraparenychmal hemorrhage was Beseoglu et al., (2009). They found this 
specific group of NASAH patients to complain of reduced mental health, which they interpreted 
as leading to emotional problems and role limitations.  
PTSD and Social Support 
Three studies have used diagnostic criteria to identify and study PTSD in subarachnoid 
hemorrhage patients (Berry, 1998; Hutter, 2000; Noble et al., 2008). The most recent study, 
Noble et al. (2008), found PTSD to occur in up to 37% of a subarachnoid hemorrhage 
population. They found PTSD to be the single best predictor of patients’ mental QOL, the 
domain most persistently impaired in both the short and long term. None of the other variables in 
their model (including clinical grade, and physical and cognitive disability) made significant 
contributions to the patients’ mental QOL.  Our study found that both groups had low levels of 
PTSD, and these levels did not differ significantly between groups. However, PTSD and social 
support were shown by regression analysis to impact HRQOL. 
To our knowledge, this is the first study to examine the effects of social support, as 
assessed with the UNC Functional Support Questionnaire (FFSQ), on the HRQOL of aneurysmal 
and nonaneurysmal hemorrhage patients. Our results demonstrated that ASAH patients, as a 
group, had low levels of PTSD and high levels of social support. The results show that patients 
with higher PTSD score (more PTSD) had lower scores on the SF-12 PCS and MCS as well as 
overall SS-QOL, indicating worse HRQOL. Patients with greater social support had higher 
overall SSQOL scores, increasing their HRQOL. These findings suggest an association between 
perceived social support, PTSD, and HRQOL for both the NASAH and ASAH groups.   
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          Fear of a second hemorrhage was a major concern for the NASAH patients. In our study, 
28 % of participants were concerned about a second subarachnoid hemorrhage, and 85% of those 
concerned also had higher levels of PTSD. Interestingly, none of the ASAH patients were 
worried about hemorrhage recurrence. For the ASAH group, this may be a result of an 
immediate treatment and potential cure via coiling or clipping for their SAH, whereas there is no 
surgical treatment for nonaneurysmal hemorrhage patients.  
Limitations 
Several study limitations deserve mention. First, the sample size was limited, falling 20 
subjects short of the goal sample of 80. Our final effect size was 0.75 based on using an alpha 
level of 0.05, HRQOL variables for both groups and an effect size of .20.  However, given the 
rarity of a NASAH, the sample size of 25 for the NASAH group is similar to that reported in four 
of the five NASAH-specific studies. The small sample size, in some cases, necessitated a 
collapse in some variables in the regression analyses. Although the 59% survey response rate 
was excellent considering that the survey was mailed and that some subjects were three years 
post-hemorrhage, the 27-page questionnaire might have been overwhelming for some subjects. 
The survey was printed in large print for ease of completion, but the resulting length may have 
discouraged some patients from responding.  
The sample may not have adequately represented the full range of SAH patients as 
severe-grade patients may have been unable to participate because of cognitive limitations. No 
screening tools were used to exclude subjects with cognitive deficits or to assist them in 
completing the questionnaire. Results are limited to English-speaking patients and those cared 
for at a large tertiary care facility only.  
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Due to the retrospective design of this study, many of the hemorrhages could have 
occurred up to up to 3.5 years earlier; thus, maturation issues should be considered.  HRQOL 
physical issues may be influenced by natural aging or by an unrelated disease process other than 
hemorrhage that has occurred with time.   
The NASAH population is heterogeneous in terms of perimesencephalic bleeding.  We 
include a variable for the NASAH subjects to distinguish between perimescencephalic and 
nonperimesencephalic. The majority were nonperimesencephalic. We would recommend further 
study in future distinguishing outcome between these two groups, similar to the Beseoglu et al., 
study in 2009 which specifically looked at outcomes between the two groups. 
As in any research, there may be a systematic bias in who agrees to participate. In this 
study, these participants may have been eager to participate because they felt that they were 
helping to advance research in this area, but it may also have been a cathartic process for them, 
or for patients who desired more follow-up.  
Human Subject Issues 
All instruments were chosen to reduce subject burden. The SS-QOL can be completed in 
12 minutes, the SF-12, FSSQ and PTSD instruments can each be completed in 5-10 minutes, and 
the demographic and NASAH-specific questionnaires in approximately 15 minutes. The risks 
involved in using these instruments are minimal. The purpose of the study was explained in both 
the initial and follow-up mailings. Participants were able to contact the PI via phone whenever 
needed. Two subjects contacted the PI requesting follow-up appointments with the 
neurosurgeon, as the study reminded them they should have followed up. One of the two patients 
corresponded with the PI and had a number of questions about her NASAH and other 
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neurological issues. Five subjects wrote letters of gratitude for the care they received and for 
researching this subject area.   
Clinical Implications 
 Nurses and other clinicians can potentially help improve several aspects of quality of life 
for SAH patients, including providing information about the affects of a SAH on HRQOL. 
Communication of information during all phases of hospitalization and follow-up was found to 
be crucial to our participants and their families.  
Our participants reported wanting more information about their diagnosis/plan of care 
during all phases of acute inpatient hospitalization, during rehabilitation, and upon discharge. 
Hutter & Gilsbach recommended back in 1995 that both ASAH and NASAH patients receive 
psychological counseling. Clinicians and nurses can refer patients to an inpatient social work 
team or to a psychiatry consultation. Much of the angst may be reduced by teaching patients 
about the natural course of subarachnoid hemorrhages. Patients with NASAH particularly need 
to hear information that they are at no more risk for a second subarachnoid hemorrhage than any 
other population. Much fear could be reduced in this population if healthcare workers could 
share the information from the Greebe and Rinkel (2007) study of perimesencephalic NASAH 
subjects showing that patients with perimesencephalic hemorrhage have no long-term excess 
mortality compared with the general population.  
Our results show that the nonaneurysmal population suffers from the same HRQOL 
issues that the aneurysmal population encounters. NASAH patients in previous studies have been 
classified as having a “good outcome” or having a “benign hemorrhage,” without having 
returned to their pre-hemorrhage level of functioning. Neurosurgery practices should consider 
referring NASAH patients to the same types of support services that the ASAH patients receive. 
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These would include physical, occupational and speech therapies. Many times, NASAH patients 
do not qualify for acute rehabilitation. In these cases, they should be given a referral for home 
occupational therapy for a home safety and cognitive evaluation.  A referral to cognitive 
neurologists should be considered for every SAH patient, particularly those who have been 
identified by occupational therapy as having cognitive deficits. ASAH and NASAH patients 
should receive psychological counseling early in the course of hospitalization to alleviate 
potential PTSD symptoms. Recognizing that these patients might suffer from PTSD and 
implementing treatment/therapy for this condition may alleviate patient fears of SAH recurrence 
and promote significantly better outcomes and decrease the risk of PTSD. Noble et al. (2008) 
also recommended early psychological intervention and suggested that teaching patients not only 
about their SAH but also better coping skills early on might prevent PTSD and improve 
HRQOL.   
Research Implications 
This is the second study to use the SSQOL in the subarachnoid hemorrhage population. 
Our findings support the use of the SSQOL with both NASAH and ASAH patients as a self-
administered tool. We would recommend using these instrument in future subarachnoid studies, 
particularly the subscales that provide direct information about both the physical and emotional 
ramifications of a subarachnoid hemorrhage.   
Surprisingly, many of the HRQOL research studies still use instruments that examine 
disability rather than HRQOL. Kim et al., in 2005, recommended using HRQOL-specific 
instruments such as the Short Form (SF)-36 rather than graded scales such as the Glasgow 
Outcome Scale or Rankin scale. Our study used two HRQOL-specific tools (SSQOL and SF-12), 
which have been validated in the subarachnoid hemorrhage population. We recommend using 
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similar HRQOL instruments. As Kim et al. reported, non-HRQOL scales such as the Barthel 
Index and National Institute of Stroke Score (NIHSS) were insensitive to subtle differences in 
cognitive recovery and reported high scores (better outcomes) although the patients had 
significant cognitive deficits. These scales give disproportionate weight to physical disability 
relative to cognitive and behavioral impairment. After subarachnoid hemorrhage, major 
cognitive deficits have been noted with detailed neuropsychological testing, even in patients who 
appeared to be “normal,” demonstrating the need to use other specific HRQOL scales that can 
also measure perception of health. We found that the SF-12 and SSQOL were self -administered 
with high levels of reliability.   
Further large-scale research or multi-site studies are needed due to the low incidence of NASAH.  
We would recommend forming a NASAH research working group across multiple centers and 
multiple countries to compare and contrast findings in this population.  
Policy Implications 
  One aspect of this study highlights the need to further understand the issue of 
employment post SAH. Unemployment or reduced employment affects both groups and certainly 
has consequences for our patients and society in general. These consequences may include 
financial hardship, debt, housing stress, family tension, boredom, alienation, and atrophying 
work skills.  Beseoglu et al., (2009) discussed whether neurological rehabilitation should be 
considered for the NASAH population. This is usually not an issue for ASAH patients as they 
generally have greater physical needs and go to a rehabilitation center. Insurance companies 
would need to consider the cost analysis of neurological rehabilitation versus the long-term costs 
and consequences of unemployment and cognitive dysfunction. In the current study, three 
subjects 2 ASAH and 1 NASAH had been denied health insurance after their SAH. Further 
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research in this population may provide insurance companies with the evidence to support 
interventions.  
Further policy work should involve collaboration on educational implications for 
NASAH patients. This was successfully done in 2007 by Hermann & Zabramski. Hermman, a 
nurse, and Zambramksi, a neurosurgeon, showed how neuroscience nurses can use evidence-
based practice to reassure and educate patients, staff members, and the public to understand the 
clinical course of NASAH. This type of publication could be created focusing on the HRQOL of 
the SAH patients involving multidisciplinary teams from neurosurgeons, cognitive neurologists, 
neuroscience nurses, social workers and physical and occupational therapists. This type of 
collaboration is commonly referred to as “team science” research.  
Conclusion  
This study is the first US study to specifically investigate HRQOL in NASAH patients 
and to examine the variable of social support and its effect on HRQOL. This is the second study 
comparing HRQOL outcomes between aneurysmal and nonaneurysmal subarachnoid 
hemorrhage patients. Our results support Hutter and Gilsbach’s (1995) findings that the 2 groups 
are much more similar than different.  
The nonaneurysmal group had more long-term physical symptoms, while the aneurysmal 
group had more long-term emotional symptoms. Only the nonaneurysmal group feared having a 
second subarachnoid hemorrhage. Both groups had low levels of PTSD, and these levels did not 
differ significantly between groups. However, PTSD and social support were shown by 
regression analysis to affect HRQOL. We recommend that clinicians assess for PTSD in all 
subarachnoid hemorrhage patients and institute treatment early, which will decrease the negative 
effects on HRQOL. This may include offering psychological services or social work early in the 
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hospital course to all SAH patients. Neurosurgery practices should consider referring NASAH 
patients to the same types of support services that the ASAH patients receive early on in the 
hospital course.  Policy changes would include advocating with insurance companies for 
NASAH patients to have similar neurological rehabilitation or at least an outpatient assessment 
by occupational therapists.   Further research and policy changes are needed to assist in 
interventions that improved vocational reintegration after SAH.  
NASAH patients should no longer be referred to as having suffered a “benign 
hemorrhage.” They have had a life changing hemorrhage that may forever change their lives and 
impact their HRQOL. 
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APPENDIX 1—Study Instruments 
Demographic Questionnaire 
Directions: Please circle the most appropriate answer to the question and fill in the blank lines if 
the question applies to you. Please try to answer all questions.  Subarachnoid Hemorrhage refers 
to the area of bleeding you had in your brain. It was the reason for your admission to Beth Israel 
Deaconess Medical Center.  
1) What is your current age (in years)?  ______________ (fill in age) 
2) Please indicate your gender:      Male (1) 
Female (2) 
3) How long ago was your subarachnoid hemorrhage? Please answer in number of 
months__________ 
4) Please indicate your race:      American Indian (1) 
Alaska Native(2)  
Asian (3)  
Black or African American (4)  
Native Hawaiian or Pacific 
Islander(5)  
Hispanic(6)  
White(7) 
Other(8)________ (please indicate)  
5) Please indicate your education level:   Some high school(1)  
High school graduate(2) 
Associates degree(3) 
 Bachelor's degree(4)  
Graduate degree(5) 
PLEASE CONTINUE TO THE NEXT PAGE 
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Other  degree(6) ____________ (please 
indicate) 
 
6) Please indicate your relationship status:     single(1) 
married(2) 
divorced(3)  
widow(4)  
partner not married(5) 
 
7) Do you drink alcohol?     Yes (1) 
No(2) 
   If yes approximately how many drinks per week __________ 
 
8) Do you currently smoke cigarettes?    Yes(1)  
No(2)  
 IF yes, for approximately how long have you been smoking ___________  
 
9) Did you ever smoke cigarettes?     Yes (1) 
No (2) 
  If yes,  for approximately how long did you smoke for ____________ 
 
PLEASE CONTINUE TO THE NEXT PAGE 
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10) Has anyone else in your family ever had a subarachnoid hemorrhage?  
Yes(1)                   
 If yes, what is their relationship to you _____________________ 
No (2) 
 
11) Who completed this survey: 
1. I completed it myself  
2. I completed it with a help of a family member or friend 
3. A family member or friend completed it for me 
PLEASE CONTINUE TO THE NEXT PAGE 
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Subarachnoid Hemorrhage Questionnaire 
Directions: Please circle the most appropriate answer to the question and fill in the blank lines if 
the question applies to you.  Please try to answer all of the questions.  Thank you. 
These questions refer to the subarachnoid hemorrhage you had in your brain which is 
bleeding into specific area of your brain 
1)Were you employed before you had the subarachnoid hemorrhage?     Yes(1)   
No(2) 
2) If you were employed, have you returned to the same position or an equivalent position?  
Yes(1) 
  No(2) 
Not Applicable(3) 
3) If you were not employed at the time of the hemorrhage, do you feel your inability to return to 
a prior or equivalent  
position is related to the subarachnoid hemorrhage?      
Yes(1) 
 
No(2) 
 
4) Have you been denied any type of health or life insurance because of the subarachnoid 
hemorrhage?  
 
Yes(1) 
 
No(2) 
 
5) Do you feel your overall quality of life has been affected by the subarachnoid hemorrhage?  
 
Yes(1) 
 
          No(2) 
 
6) Do you currently experience physical symptoms as a direct result of the subarachnoid 
hemorrhage?   
 
 Yes(1) 
 
 No(2)  
PLEASE CONTINUE TO THE NEXT PAGE 
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If you currently have physical symptoms related to the subarachnoid hemorrhage - please 
list the physical symptoms below:  
 
  __________________________________________________ 
 
  __________________________________________________ 
 
  ___________________________________________________ 
 
 
7. Do you currently experience emotional, or psychological symptoms as a direct result of the 
subarachnoid hemorrhage?  
          Yes(1) 
 
 No(2)  
 
If YES – please list these emotional/psychological symptoms:  
  __________________________________________________ 
 
  __________________________________________________ 
 
  ___________________________________________________ 
 
 
7) Did you receive outpatient physical therapy as a result of the subarachnoid hemorrhage?  
          
          Yes(1) 
 
 No(2)  
 
 
If yes, for how long?___________ 
 
8) How helpful was physical therapy?      Very Helpful (2) 
 
        Somewhat Helpful (1) 
 
        Not Helpful (0)    
 
9) Did you receive outpatient occupational therapy as a result of the subarachnoid hemorrhage?  
          
          Yes(1) 
 
 No(2)  
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PLEASE CONTINUE TO THE NEXT PAGE 
 
If you received outpatient occupational therapy how long did you receive it for? 
_______________ 
 
10) How helpful was occupational therapy?     Very Helpful (2) 
 
        Somewhat Helpful (1) 
 
        Not Helpful (02    
 
 
11) Did you receive outpatient speech therapy as a result of the subarachnoid hemorrhage?  
          
          Yes(1) 
 
 No(2)  
 
If yes, for how long?___________ 
 
12) How helpful was speech therapy?      Very Helpful (1) 
 
        Somewhat Helpful (1) 
 
        Not Helpful (0)    
 
13) Did you receive any psychological counseling as a result of your SAH?  
          
          Yes(1) 
 
 No(2)  
 
 
If yes, for how long?___________ 
 
14) How helpful was the psychological counseling?    Very Helpful (2) 
 
        Somewhat Helpful (1) 
 
        Not Helpful (0)    
 
15) Did you use or receive any other type of treatment or service that helped your recovery from 
the subarachnoid hemorrhage?          
  
          Yes(1) 
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 No(2)  
 
 
 
PLEASE CONTINUE TO THE NEXT PAGE 
 
 If you receive other treatment or service what was it? _______________________ 
 
 
 
how long did you receive it?___________ 
 
16) How helpful were other treatments or service?      Very Helpful (2) 
 
        Somewhat Helpful (1) 
 
        Not Helpful (0)    
 
 
 
 
12) Is there any type of treatment(s) or service(s) you wish you had available to you during your 
recovery?  
        
          Yes(1) 
 
 No(2)  
 
 
If yes, what type of treatment or service would you have liked? 
 
_________________________________________________________ 
__________________________________________________________ 
 
 
 
 
 
 
 
 
PLEASE CONTINUE TO THE NEXT PAGE 
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Instructions: Please circle then number to indicate how much you have 
experienced each symptom in the past week, including today. Please answer all the items. 
 Not at all  
1
  
  
Somewhat
2
  
Moderately
3
  
A Lot 
4 
  
Extremely
5
1. Upsetting memories of a 
your brain bleed that come 
into your mind over and over 
 1 2 3 4 5 
2. Avoiding things, places or 
upsetting thoughts associated 
with the brain bleed 
 1 2 3 4 5 
3. Loss of interests or 
participation in activities 
 1 2 3 4 5 
4. Feeling isolated or 
alienated from other people 
 1 2 3 4 5 
5. Flashbacks (feeling like the 
past upsetting event is 
happening in the present) 
 1 2 3 4 5 
6. Always being on the 
lookout to make sure you 
don’t experience the brain 
bleed again 
 1 2 3 4 5 
7. Feelings of guilt or distress 
about the brain bleed event 
 1 2 3 4 5 
8. Strong physical sensations 
(increased heart rate, 
sweating, etc.) when you are 
reminded about the brain 
bleed. 
Continue to next page 
 1 2 3 4 5 
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 Not at all  
1
  
  
Somewhat
2
  
Moderately
3
  
A Lot 
4 
  
Extremely
5
9. Feelings of numbness  1 2 3 4 5 
10. Difficulty falling or 
staying asleep 
 1 2 3 4 5 
   
Reprinted and used with permission from the Trauma Awareness & Treatment Center TATC 
PTSD 
PLEASE CONTINUE TO THE NEXT PAGE 
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Duke–UNC Functional Social Support Questionnaire (FSSQ) 
Here is a list of some things that other people do for us or give us that may be helpful or 
supportive. Please read each statement carefully and circle the number closest to your situation. 
Give only 1 answer per row. 
 5. As much as 
I would like 
 
4. Almost as 
much as I 
would like 
 
3. Some, but 
would like 
more 
 
2.Less than I 
would like 
 
1. Much less 
than I would 
like 
 
1. I have 
people who 
care 
what happens 
to me. 
 
5 4 3 2 1 
2. I get love 
and affection. 
 
5 4 3 2 1 
3. I get 
chances to talk 
to someone 
about 
problems at 
work or 
with my 
housework. 
 
5 4 3 2 1 
4. I get 
chances to talk 
to someone I 
trust 
about my 
personal or 
family 
problems. 
 
5 4 3 2 1 
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5. I get 
chances to talk 
about money 
matters. 
 
5 4 3 2 1 
6. I get 
invitations to 
go out and do 
things 
with other 
people. 
 
5 4 3 2 1 
7. I get useful 
advice about 
important 
things in life. 
 
5 4 3 2 1 
 5. As much as 
I would like 
 
4. Almost as 
much as I 
would like 
 
3. Some, but 
would like 
more 
 
2.Less than I 
would like 
 
1. Much less 
than I would 
like 
 
8. I get help 
when I 
am sick in 
bed. 
5 4 3 2 1 
Source Adultmeducation.com available on web no source to request permission.  
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SF-12® Patient Questionnaire 
 
Directions:  Answer every question by circling the appropriate answer. If you are unsure about 
how to answer a question, please give the best answer you can and make a written comment 
beside your answer. 
 
1. In general, would you say your health is: 
Excellent (1) 
Very Good (2) 
Good (3) 
 Fair (4) 
 Poor (5) 
 
The following two questions are about activities you might do during a typical day. Does YOUR 
HEALTH NOW LIMIT YOU in these activities? If so, how much? 
 
2. MODERATE ACTIVITIES, such as moving a table, pushing a vacuum cleaner, bowling, or 
playing 
golf: 
 Yes, Limited A Lot (1) 
 Yes, Limited A Little (2) 
 No, Not Limited At All (3) 
 
3. Climbing SEVERAL flights of stairs: 
Yes, Limited A Lot (1) 
Yes, Limited A Little (2) 
No, Not Limited At All (3) 
 
During the PAST 4 WEEKS have you had any of the following problems with your work or 
other regular activities AS A RESULT OF YOUR PHYSICAL HEALTH? 
 
4. ACCOMPLISHED LESS than you would like: 
 Yes (1) 
 No (2) 
 
5. Were limited in the KIND of work or other activities: 
Yes (1) 
 No (2) 
 
During the PAST 4 WEEKS, were you limited in the kind of work you do or other regular 
activities AS A RESULT OF ANY EMOTIONAL PROBLEMS (such as feeling depressed or 
anxious)? 
 
6. ACCOMPLISHED LESS than you would like: 
 Yes (1) 
 No (2)                                   SF-12® PLEASE CONTINUE TO THE NEXT PAGE 
 
 HRQOL in Subarachnoid Hemorrhage Patients 
119 
 
7. Didn’t do work or other activities as CAREFULLY as usual: 
 Yes (1) 
 No (2) 
 
8. During the PAST 4 WEEKS, how much did PAIN interfere with your normal work (including 
both work outside the home and housework)? 
 
 Not At All (1) 
 A Little Bit (2) 
 Moderately (3) 
Quite A Bit (4) 
 Extremely (5) 
 
The next three questions are about how you feel and how things have been DURING THE PAST 
4 
WEEKS. For each question, please give the one answer that comes closest to the way you have 
been 
feeling. How much of the time during the PAST 4 WEEKS – 
 
9. Have you felt calm and peaceful? 
 All of the Time (1) 
Most of the Time (2) 
 A Good Bit of the Time (3) 
 Some of the Time (4) 
 A Little of the Time (5) 
None of the Time (6) 
 
10. Did you have a lot of energy? 
 All of the Time (1) 
Most of the Time (2) 
 A Good Bit of the Time (3) 
Some of the Time (4) 
A Little of the Time (5) 
None of the Time (6) 
 
11. Have you felt downhearted and blue? 
All of the Time (1) 
 Most of the Time (2) 
 A Good Bit of the Time (3) 
 Some of the Time (4) 
A Little of the Time (5) 
 None of the Time (6) 
 
SF-12® PLEASE CONTINUE TO THE NEXT PAGE 
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12. During the PAST 4 WEEKS, how much of the time has your PHYSICAL HEALTH OR 
EMOTIONAL PROBLEMS interfered with your social activities (like visiting with friends, 
relatives, etc.)? 
 All of the Time (1) 
Most of the Time (2) 
A Good Bit of the Time (3) 
Some of the Time (4) 
 A Little of the Time (5) 
 None of the Time (6) 
 
 
SF-12® Health Survey © 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All Rights Reserved 
SF-12® is a registered trademark of Medical Outcomes Trust; Reprinted  and used with permission 
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SS-QOL V2.0 Copyright  Linda S. Williams, MD 1999 
We would like to know how you’re doing with activities or feelings that can sometimes be 
affected by a subarachnoid hemorrhage. Each question will ask about a specific activity or 
feeling. For each question, think about how that activity or that feeling has been in the past 
week. The first group of questions asks about how much trouble you have with a specific 
activity. Each question deals with problems that some people have after their subarachnoid 
hemorrhage. Circle the number in the box that best describes how much trouble you have had 
with that activity in the past week.  
 
DURING THE PAST WEEK 
  
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
SC1. I did have trouble 
preparing food?  
 
 
1 2 3 4 5 
 
SC2. I did have  
trouble eating, for  
example, cutting food or 
 swallowing?  
 
 
1 2 3 4 5 
 
SC4. I did have  
trouble getting dressed, 
 for example, putting on 
 socks or shoes,  
buttoning buttons, or  
zipping?  
 
 
1 2 3 4 5 
 
SC5. I did  have  
trouble taking a bath or  
shower? 
Continue to next page 
 
 
1 2 3 4 5 
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Strongly 
agree  
 
 
Moderately 
 agree  
 
 
Neither  
agree nor 
disagree  
 
 
Moderately  
disagree  
 
 
Strongly 
disagree 
 
 
 
SC8. I did have  
trouble using the toilet?  
 
 
 
 
1 2 3 4 5 
 
 
V1. I did have  
trouble seeing the  
television well enough  
to enjoy a television  
show? 
 
 
 
1 2 3 4 5 
 
V2. I did have  
trouble reaching for  
things because of poor  
eyesight?  
 
 
1 2 3 4 5 
V3. I did have  
trouble seeing things off  
to one side? 
1 2 3 4 5 
 
L2. I did have 
 trouble speaking, for  
example, get stuck, 
 stutter, stammer, or slur 
 my words?  
 
 
 
 
1 2 3 4 5 
CONTINUE TO 
NEXT PAGE 
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Strongly 
agree  
 
 
Moderately 
 agree  
 
 
Neither  
agree nor 
disagree  
 
 
Moderately  
disagree  
 
 
Strongly 
disagree 
 
 
 
L3. I did  have 
 trouble speaking clearly 
 enough to use the 
 telephone?  
 
 
1 2 3 4 5 
 
L6. I did have trouble 
finding the 
words I  wanted 
to say?  
 
 
1 2 3 4 5 
L7. I did need to repeat 
myself so others could 
understand me? 
1 2 3 4 5 
 
M4. I did lose   
my balance when 
 bending over or 
reaching for  
for something? 
 
 
1 2 3 4 5 
 
M6. I did  have  
trouble climbing the 
stairs?  
 
 
1 2 3 4 5 
 
M7.I did  have  
trouble with needing to  
stop and rest when  
walking or using a  
wheelchair?  
 
 
1 2 3 4 5 
CONTINUE      
TO NEXT PAGE 
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Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
 
M8. I did have  
trouble with standing? 
 
 
 
 
 
1 2 3 4 5 
 
M9. I did have  
trouble getting out of  
a chair ? 
 
 
1 2 3 4 5 
 
W1. I did have  
trouble doing daily work 
 around the house?  
 
 
1 2 3 4 5 
 
W2. I did  have  
trouble finishing jobs  
that I started?  
 
 
1 2 3 4 5 
 
W3. I did have   
trouble doing the  
 work I used to do?  
 
 
1 2 3 4 5 
 
UE1. I did have trouble 
writing or typing 
 
 
1 2 3 4 5 
 
UE2. I did have  
trouble putting on 
socks? 
1 
 
 
NEXT 
2 
 
 
PAGE 
3 4 5 
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CONTINUE TO  
 
 
  
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
      
 
UE3. I did  have  
trouble buttoning 
buttons?  
 
 
1 2 3 4 5 
 
UE5. I did have  
trouble zipping a zipper?  
 
 
1 2 3 4 5 
 
UE6. I did have  
trouble opening a jar?  
 
 
1 2 3 4 5 
 
The next set of questions asks about how much you agree or disagree with each statement. Each 
question deals with a problem or feeling that some people have after their subarachnoid 
hemorrhage. Circle the number in the box that best says how you felt about each statement 
during the past week.  
 
  
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
T2. It was hard for me  
to concentrate.  
 
 
1 2 3 4 5 
CONTINUE TO  
NEXT PAGE 
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Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
T3. I had trouble  
remembering things.  
 
 
1 2 3 4 5 
 
T4. I had to write things 
 down to remember  
them.  
 
 
1 2 3 4 5 
 
P1. I was irritable.  
 
1 2 3 4 5 
 
P2. I was impatient with  
others  
 
 
1 2 3 4 5 
 
P3. My personality has  
changed.  
 
 
1 2 3 4 5 
  
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
MD2. I was discouraged 
 about my future 
 
 
 
1 2 3 4 5 
CONTINUE TO  
NEXT PAGE 
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Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
MD3. I wasn’t   
interested in other  
people or activities. 
 
  
 
 
1 2 3 4 5 
 
FR5. I didn’t join in  
activities just for fun  
with my family.  
 
 
1 2 3 4 5 
 
FR7. I felt I was a  
burden to my family.  
 
 
1 2 3 4 5 
 
FR8. My physical  
condition interfered with 
 my family life 
 
 
1 2 3 4 5 
 
SR1. I didn’t go out as  
often as I would like.  
 
 
1 2 3 4 5 
 
SR4. I did my hobbies  
and recreation for  
shorter periods of time  
than I would like. 
 
 
1 2 3 4 5 
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CONTINUE TO 
NEXT PAGE 
 
 
  
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
SR5. I didn’t see as  
many of my friends as I 
 would like.  
 
 
1 2 3 4 5 
 
SR6. I had sex less often  
than I would like. 
 
 
1 2 3 4 5 
SR7. My physical  
condition interfered with 
my social life. 
1 2 3 4 5 
 
MD6. I felt withdrawn  
from other people.  
 
 
1 2 3 4 5 
 
MD7. I had little  
confidence in myself.  
 
 
1 2 3 4 5 
 
MD8. I was not  
interested in food.  
 
 
1 2 3 4 5 
 
E3. I had to stop and rest 
often during the 
day.  
 
 
1 2 3 4 5 
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E2. I felt tired most of  
the time.  
 
 
1 2 3 4 5 
CONTINUE TO NEXT  PAGE 
Strongly 
agree  
 
 
 
Moderately 
 agree  
 
 
 
Neither  
agree nor 
disagree  
 
 
 
Moderately  
disagree  
 
 
 
Strongly 
disagree 
 
 
 
 
E4. I was too tired to 
 do what I wanted to  
do.  
 
 
 
 
 
1 2 3 4 5 
Now, we would like to ask how you feel you are doing today in some general areas compared to how you 
were before your subarachnoid hemorrhage. Please circle the number in the box that corresponds to 
whether each area is a lot worse, a little worse, or the same as before your subarachnoid hemorrhage. 
Please remember to compare how you are doing today with how you were before your subarachnoid 
hemorrhage (SAH).  
  
  
 
a lot 
worse 
than 
before 
my SAH 
 
 
 
 
 
 
 
somewhat 
worse than 
before my 
SAH  
 
 
 
 
 
a little 
worse than 
before my 
SAH  
 
 
 
 
 
 
 
the same as 
before my 
SAH  
 
 
 
1E. My energy level is?  
 
 
1 2 3 4 
 
2L. My speech is  
 
1 2 3 4 
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3M. My walking is  
 
 
1 2 3 4 
CONTINUE TO THE  
4V. My vision is  
 
NEXT PAGE   
  
  
 
a lot 
worse 
than 
before 
my SAH 
 
 
 
 
 
 
 
somewhat 
worse than 
before my 
SAH  
 
 
 
 
 
a little 
worse than 
before my 
SAH  
 
 
 
 
 
 
 
the same as 
before my 
SAH  
 
 
     
 
5UE. The use of my 
arms or hands is  
 
 
1 2 3 4 
 
 
6T. My thinking is  
 
 
 
 
1 2 3 4 
 
7MD. My mood is  
 
 
1 2 3 4 
 
8P. My personality is  
 
 
1 2 3 4 
 
9W. I do my jobs at  
home or at work  
 
 
1 2 3 4 
 1 2 3 4 
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10SC. I can take care of  
myself 
 
 
11FR. I do things for my 
 family  
 
 
1 2 3 4 
  
  
 
a lot 
worse 
than 
before 
my SAH 
 
 
 
 
 
 
 
somewhat 
worse than 
before my 
SAH  
 
 
 
 
 
a little 
worse than 
before my 
SAH  
 
 
 
 
 
 
 
the same as 
before my 
SAH  
 
 
 
12SR. I do things for my 
Friends.  
 
 
1 2 3 4 
 
13. Overall, my quality 
of life is: 
 
 
 
1 2 3 4 
 
SS-QOL V2.0 
Copyright  Linda S. Williams, MD 1999; Reprinted and used with permission 
 
THE END 
THANK YOU FOR YOUR PARTICPATION  
PLEASE PLACE IN STAMPED ENVELOPE THAT WAS PROVIDED 
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Appendix 2 Mailing Materials 
RESEARCH STUDY ON HEALTH RELATED QUALITY OF LIFE AFTER 
SUBARACHNOID HEMORRHAGES 
Welcome! We are requesting your participation in a research study being conducted on patients 
who have suffered a subarachnoid hemorrhage in the last three years and were treated at Beth 
Israel Deaconess Medical Center. A subarachnoid hemorrhage is a type of brain bleed which 
occurs in the subarachnoid space in the brain. It can be caused by an aneurysm or by a venous 
vessel that bleeds without warning. In particular we are interested in your experiences and 
changes that have occurred in your life since this brain bleed. This study is being conducted by 
Chip McIntosh, NP, (PhD candidate at University of Massachusetts Worcester) and nurse 
practitioner for the division of neurosurgery at Beth Israel Deaconess Medical Center in Boston 
Massachusetts.  
The survey on the following pages should take less than 30 minutes to complete. Most 
questions only require a simple circle. The information collected may help us to better 
understand the impact of a subarachnoid hemorrhage on your quality of life. The information 
may be used in future to help guide other research in order to improve quality of life for those 
patients who may develop a subarachnoid hemorrhage. We hope you will share your experiences 
with us through this study and we request you respond in a frank and open manner.  To protect 
your privacy, the survey is confidential and no identifying information will appear on the survey 
form.  Each survey will have a code number, however, to help us track participation rate, 
information connecting code numbers with specific study participants will be maintained during 
the 8 week data collection period and then this tracking sheet will be destroyed so no individual 
data can be connected back to an individual participant.  
Although there are no known risks for your participation, the questions may prompt concerns or 
questions about events around your subarachnoid hemorrhage or future treatment. You may 
contact the researcher, (contact information below) to answer any questions or concerns. 
Participating in this survey is purely voluntary. There are no consequences for declining to 
participate and you are under no obligation to take part in this study.  There are no benefits for 
participation but we hope you will experience satisfaction knowing that your information may 
help inform the field about quality of life after subarachnoid hemorrhages. If you choose to 
participate a $5.00 gift card will be mailed to you once we receive your completed surveys. If 
you choose not to participate we would ask that you return the blank packet in the self addressed 
envelope.  
Your completion and return of the survey in the enclosed self-addressed stamped envelope 
indicates your consent to participate.  In order to further protect your confidentiality, please do 
not include any return address or other identifying information on the envelope or the survey 
itself.   
If you have any questions about this research, please feel free to contact the researcher at the 
contact information below.  If you have questions about the project’s protection of human 
subjects, please contact the Human Subjects Protection Office at Beth Israel Deaconess Medical 
Center, 109 Brookline Ave Boston, MA 02215. Or via phone at 617-667-4524. 
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Sincerely, Chip McIntosh, NP, amcintos@bidmc.harvard.edu 617-632-7246 
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Reminder Card 
Dear Sir/Ma’am: 
You should have received a request to participate in a research study approximately 2 week ago. 
We are requesting your participation in a research study being conducted on patients who have 
suffered a subarachnoid hemorrhage in the last three years and were treated at Beth Israel 
Deaconess Medical Center.  
The information you provide will help inform the medical field about quality of life after 
subarachnoid hemorrhages. If you choose to participate a $5.00 gift card will mailed to you once 
we receive your completed surveys. If you choose not to participate we would ask that you return 
the blank survey in the self addressed envelope. We hope you choose to participate and will send 
back your surveys soon.  
 
If you have not received a packet or need a new one please contact Chip McIntosh, NP,  
amcintos@bidmc.harvard.edu 617-632-7246. 
 
If you have already returned your packet—thank you! Please disregard this message.  
Thank You Card 
 
Dear Sir/Ma’am: 
 
Thank you so much for participating in the subarachnoid hemorrhage quality of life study. The 
information you have provided is extremely valuable. It may help patients who will suffer 
subarachnoid hemorrhages in the future. Thank you for your time and effort, enclosed is your 
gift card. 
 
Sincerely, 
Chip McIntosh, NP,  
Clinical Manager and Nurse Practitioner Division of Neurosurgery 
Beth Israel Deaconess Medical Center 
PhD student in Nursing at UMass Worcester 617-632-7246 
